Diane C. Bodurka, M.D., MPH
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
About Dr. Diane C. Bodurka
Diane C. Bodurka, M.D., MPH, is a Professor in the Department of Gynecologic Oncology and Reproductive Medicine at UT MD Anderson Cancer Center, where she serves as Vice President and Chief Education & Training Officer, Designated Institutional Official (DIO), Assistant Dean of the Graduate School of Biomedical Sciences, and Associate Director of the Cancer Center Support Grant (CCSG). A nationally recognized clinician-educator and academic leader, she has held continuous faculty appointments at MD Anderson since 1994 and is board-certified in Obstetrics and Gynecology and Gynecologic Oncology. In her executive roles, she provides institutional oversight for graduate medical education, interprofessional training, accreditation, and academic program development across the cancer center.
Within the CCSG, Dr. Bodurka plays a central leadership role in the Cancer Research Education and Training Core (CRTEC), also known as Cancer Research Career Enhancement and Related Activities (CRCE). As Co-Director of CRTEC, she leads strategic planning, implementation, and evaluation of comprehensive cancer research training and career development programs that span predoctoral, postdoctoral, clinical, and early-stage investigator levels. Her work strengthens the cancer research workforce pipeline by advancing mentorship excellence, structured professional development, workforce diversity initiatives, and rigorous outcomes assessment aligned with national priorities in cancer research training.
Dr. Bodurka’s scholarship spans gynecologic oncology, survivorship, quality of life, patient safety, and academic medicine. She has served as Principal Investigator or Co-Principal Investigator on multiple NIH- and NCI-funded grants, including T32 training programs and SPORE career development initiatives, reflecting her longstanding commitment to developing physician-scientists and interdisciplinary cancer researchers. She is also widely recognized for clinical excellence, with multiple national and regional honors—including repeated recognition as a Top Doctor and national provider performance distinctions—along with institutional awards for excellence in teaching, leadership, and mentoring. Through innovations such as standardized handoff communication (I-PASS), quality improvement education, and shared medical appointments, she has advanced both patient safety and the clinical learning environment while mentoring generations of trainees.
Present Title & Affiliation
Primary Appointment
Assistant Dean, Graduate School of Biomedical Sciences (GSBS), The University of Texas MD Anderson Cancer Center UTHealth, Houston, Texas
Vice President, Chief Education & Training Officer, The University of Texas MD Anderson Cancer Center, Houston, TX
Accreditation Liaison, Southern Association of Colleges and Schools - Commission on Colleges, The University of Texas MD Anderson Cancer Center, Houston, TX
Designated Institutional Official, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Bette Leeds Chair in Gynecology Research and Therapy of Ovarian Cancer, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Accreditation Liaison, Southern Association of Colleges and Schools - Commission on Colleges, The University of Texas MD Anderson Cancer Center, Houston, TX
Term Tenure Renewed, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
The University of Texas Distinguished Teaching Professor, The University of Texas System, Austin, TX
Term Tenure Renewed, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
I am a Health Services Researcher with a focus on survivorship, quality of life, and cancer outcomes. I have successfully collaborated with investigators in other disciplines to study multiple areas crucial to the Health Services Research spectrum as it pertains to gynecology oncology. I have assessed the impact of clinical and demographic factors of survivors upon quality of care, and am currently evaluating age-related barriers to survivorship care from the perspectives of health care providers and patients. This is an essential first step toward transforming the health care system to accommodate the growing ranks of survivors. The long-term goal of my research is to develop strategies to better distribute access to comprehensive, evidence-based survivorship care and to shape policy in this area.
Education & Training
Degree-Granting Education
| 2014 | The University of Texas School of Public Health, Houston, TX, US, Health Services Organization, MPH |
| 1990 | Georgetown University School of Medicine, Washington, D.C, US, MD |
| 1983 | The University of California, Los Angeles, California, US, Psychobiology, BS |
Postgraduate Training
| 2025-2025 | Artificial Intelligence in Health Care, MIT Sloan School of Management, Houston, Texas |
| 2024-2024 | 2024 UHN Virtual Interprofessional Teaching & Learning (VITAL), The University of Toronto Center for Advancing Collaborative Healthcare & Education, Toronto, Ontario |
| 2023-2024 | Council of Deans Fellowship Program, Association of American Medical Colleges, Washington, D.C, District of Columbia |
| 2022-2023 | Data Equity Fellowship, Northwest Commission on Colleges – Southern Association of Colleges and Schools Commission on Colleges, Redmond, Washington |
| 2022-2022 | Promoting Professionalism, Vanderbilt University Medical Center, Nashville, TN |
| 2020-2020 | MD Anderson Coach RICE Program, The University of Texas MD Anderson Cancer Center Leadership Institute in conjunction with The Rice University Doerr Institute for New Leaders, Houston, TX |
| 2020-2020 | Leading Difference for High Performance, Harvard Business School, Boston, MA |
| 2019-2019 | Academic Peer Evaluator Training, Southern Association of Colleges and Schools Commission on Colleges (SACSCOC), Houston, TX |
| 2019-2019 | Management and Finance, Harvard Business School, Boston, Massachusetts |
| 2019-2019 | Texas Executive Enterprise Risk Management Workshop, MD Anderson Leadership Institute Strategic Decision and Risk Management Training, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2019-2019 | The Women's Leadership Forum, Harvard Business School, Boston, MA |
| 2018-2018 | Health Education Fellowship Program, UT Health McGovern Medical School, Houston, TX |
| 2014-2014 | Scholarly Writing, Publishing Medical Education Research, Medical Education Research Certificate (MERC) Workshop, Chicago, IL |
| 2014-2015 | Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Fellowship Program, Duke University, Durham, NC |
| 2014-2014 | Value-Based Health Care Delivery Leadership Course, Texas Medical Center, Houston, TX |
| 2014-2014 | Clinical Safety and Effectiveness Program, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2013-2013 | Graduate Certificate in Health Care Management, Rice University, Houston, TX |
| 2013-2013 | Women Don't Ask: Negotiate for What You Deserve, Course Participant, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2013-2013 | Selecting the Right People: A Behavior-Based Approach, Excellence in Leadership Series, Course Participant, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2012-2012 | Difficult Conversations in Mentoring, Supervision and with Colleagues: A Workshop for Women Faculty, Course Participant, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2012-2012 | Boosting Your Presentation Confidence Through Tangible Skills, Course Participant, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2011-2011 | How to Write Successful Grants, Course Participant, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2005-2005 | Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1998-1998 | Measurement, Design and Analysis Methods for Health Outcomes Research, The Department of Biostatistics and the Center for Continuing Professional Education, Harvard School of Public Health, Boston, MA |
| 1994-1996 | Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1990-1994 | Internship and Residency, Obstetrics and Gynecology, The University of Alabama, Birmingham, AL |
| null-2024 | Ehpic It’s About Health, The University of Toronto Center for Advancing Collaborative Healthcare & Education, Toronto, Ontario |
Licenses & Certifications
| 2021 | Florida Medical Board |
| 2016 | American Board of Medical Quality, Certified in Medical Quality |
| 1999 | American Board of Obstetrics and Gynecology |
| 1997 | American Board of Obstetrics and Gynecology |
| 1994 | Texas Medical Board |
| 1994 | DEA |
Experience & Service
Faculty Academic Appointments
Ashbel Smith Professor, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2018
Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2003 - 2008
Assistant Professor (tenure track), Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2000 - 2003
Assistant Professor (non-tenure track), Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center (non-tenure track), Houston, TX, 1996 - 2000
Junior Faculty Associate, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1994 - 1996
Administrative Appointments/Responsibilities
Campus Security Authority, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - Present
Coordinating Official, National Science Foundation, Alexandria, VA, 2021 - Present
Associate Director Anderson's Cancer Center Support Grant, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Co-Director, Cancer Research Career Enhancement and Related Activities, Cancer Center Support Grant, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Assistant Dean, Graduate School of Biomedical, The University of Texas MD Anderson Cancer Center UTHealth Houston, Houston, TX, 2018 - Present
Vice President, Chief Education & Training Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Dyad Co-Leader, Institutional Operational Priority - Education, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2018
Founding Member, High Value Practice Academic Research Alliance, Baltimore, MD, 2016 - Present
Executive Director, Simulation Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2020
Team, Co-Leader, Strategic Plan, Training and Manpower Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Chair, Strategic Plan, Clinical Education Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2021
Director of Education, Physician Assistant Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2018
Co-Chair, Prevention, Health Services Research, Survivorship and QI Research Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2016
Designated Institutional Official, The Accreditation Council for Graduate Medical Education, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present
Vice President for Clinical Education, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2017
Leader, Health Services Research Theme for the Department of Gynecologic Oncology and Reproductive Medicine, Cancer Center Support Grant, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2012
Director, Career Development Program of Uterine SPORE, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2010 - 2016
Member, Executive Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013
Director, Health Services Research Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013
Medical Director, Advanced Practice Nurse Midlevel Providers, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2011
Rotation Coordinator, Step-Up Biomedical Engineering/Bioengineering Student Interns, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2010
Co-Director, Career Development Program for the Uterine SPORE, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2022
Director, Gynecologic Oncology Rotation for Hematology/Oncology Fellows, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Chair, Physician-Scientist Research Track Steering Committee, NIH/NCI T32 Training of Academic Gynecologic Oncologists, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2016
Director, NIH/NCI T32 Training of Academic Gynecologic Oncologists, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2016
Chair, Program Steering Committee, NIH/NCI T32 Training of Academic Gynecologic Oncologists, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2016
Chair, Population-Based Research Track Steering Committee, NIH/NCI T32 Training of Academic Gynecologic Oncologists, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2016
Chair, Institutional Committee, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2005 - 2007
Chair, Fellowship Planning Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2012
Director, Fellowship Training Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2012
Co-Director, Ovarian Cancer Screening Clinic, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2005
Program Director, Resident Rotations, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2012
Director, Felix Rutledge Fellow Rotating Resident Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2012
Director, Ovarian Cancer Screening Clinic, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2001
Assistant Director, Fellowship Training Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2001
Other Professional Positions
Campus Security Authority, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Coordinating Official, National Science Foundation, Alexandria, VA, 2021
Founding Member, High Value Practice Academic Research Alliance, Baltimore, MD, 2016 - Present
Member, Council on Education, Subcommittee for Academic Physicians, The University of Texas Regents Teaching Awards Peer Review Committee, Austin, TX, 2014 - Present
Member, Medical/Graduate Medical Education Stakeholders Workgroup, Texas Medical Board, Austin, TX, 2013 - Present
Member, Quality & Outcomes Registry Development Work Group, Society of Gynecologic Oncology, Chicago, IL, 2010 - 2012
Member, Comparative Effectiveness Research Working Group, Gynecologic Oncology Group, Philadelphia, PA, 2010 - 2011
Member, Innovations in Health Education Awards Committee, The University of Texas Academy of Health Science Education, Austin, TX, 2009 - Present
Scientific Advisory Committee, Genentech, San Francisco, CA, 2009 - 2012
Member, The University of Texas Academy of Health Science Education, Austin, TX, 2008 - Present
Member, Hereditary Cancer Panel, Society of Gynecologic Oncology, Chicago, IL, 2008 - 2009
Member, Oncology Training Programs Workforce Subcommittee, American Society of Clinical Oncology, Washington, D.C, 2007 - 2012
Member, Workforce Implementation Group, American Society of Clinical Oncology, Washington, D.C, 2007 - 2012
Consultantships, Merck, Speaker's Bureau, Whitehouse Station, NJ, 2006 - 2009
Member, Oncology Training Programs Committee, American Society of Clinical Oncology, Washington, D.C, 2005 - 2012
Chair, Program Directors' Task Force, Society of Gynecologic Oncology, Chicago, IL, 2005 - 2009
Member, Council on Medical Education, Texas Medical Association, Austin, TX, 2005 - 2007
Member, Practice Survey Task Force, Society of Gynecologic Oncology, Chicago, IL, 2005 - 2006
Member, Council on Education, Subcommittee for Academic Physicians, American Society of Clinical Oncology, Washington, D.C, 2003 - 2008
Member, Oncology Workforce Taskforce, American Society of Clinical Oncology, Washington, D.C, 2003 - 2007
Member, Managed Care Task Force, Society of Gynecologic Oncology, Chicago, IL, 2003 - 2004
Member, Health Services Research Committee, American Society of Clinical Oncology, Washington, D.C, 2002 - 2005
Consultantships, Web.md, Washington, D.C, 2000 - 2010
Consultantships, Oncology.com, Washington, D.C, 2000 - 2010
Member, Clinical Data Network Committee, Society of Gynecologic Oncology, Chicago, IL, 2000 - 2003
Member, Quality of Life Committee, Gynecologic Oncology Group, Philadelphia, PA, 1999 - 2009
Member, Data Management Committee, Gynecologic Oncology Group, Philadelphia, PA, 1998 - 2009
Member, Ad Hoc Committee on Genetics, Texas Medical Association, Austin, TX, 1998 - 2005
Extramural Institutional Committee Activities
Member, Research Communities (Faculty-Staff-Trainees), RTPD Workstream of Research Focus Areas, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Executive Order Taskforce, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Incident Command, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Health Care Administration, Leadership, and Management (HALM), Accreditation Council for Graduate Medical Education, 2024 - Present
Co-Lead, Education Workstream, MD Anderson – UT Dell Medical Complex Project, The University of Texas MD Anderson Cancer Center, 2024
Member, Mentor Training, Trainee Retention, and Program Evaluation Core - Division of Cancer Medicine T-32 Fellowship Program, The University of Texas MD Anderson Cancer Center, 2024
Member, Clinical Core Leadership Team, The University of Texas MD Anderson Cancer Center, 2024
Member, Enterprise Project Advisory Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Key Steward, High Value Asset Assessment Steering Committee, The University of Texas MD Anderson Cancer Center, 2022
Member, International Travel Oversight Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Strategic Position Management Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Award Chair, Harter Prize for Research, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Center for Professionalism Support & Success: Peer Messenger, The University of Texas MD Anderson Cancer Center, 2022 - Present
Co-Sponsor, Academic Mentoring Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Member, High Reliability Education Workgroup, The University of Texas MD Anderson Cancer Center, 2021
Co-lead, U54 FIRST Program, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Academic Advisory Council, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Future of Work Leadership Team, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, PCCSM Selection Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Academic Policy Council, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, 2021 Brown Foundation Award for Excellence in Oncology Nursing Selection Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Project Advocate, South Campus Education Building/ 1MC Relocation, The University of Texas MD Anderson Cancer Center, 2021 - Present
Campus Security Authority, Jeanne Clery Disclosure of Campus Security, The University of Texas MD Anderson Cancer Center, 2021
Coordinating Official, National Science Foundation, The University of Texas MD Anderson Cancer Center, 2021
Co-Sponsor, Patient Handoff Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, MD Anderson Cancer Center, Alumni Association, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Quality Education Project Executive Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Listen, Learn, Act Survey, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, President's Advisory Council, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Cancer Center Support Grant Executive Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Research and Academic IT Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Master Facilities Framework 2030 Core Team, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Internal Advisory Board for the CPRIT Research Training Program, The University of Texas MD Anderson Cancer Center, 2019 - Present
Ex-officio Member, End of Life Subcommittee of the Operational Priority Care Planning Committee Provider Education Taskforce, The University of Texas MD Anderson Cancer Center, 2019 - 2022
Co-Chair, UTHealth – The University of Texas MD Anderson Cancer Center Population Health Education & Training Workgroup, The University of Texas MD Anderson Cancer Center, 2019 - 2020
Member, Cost Accounting Executive Steering Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2020
Member, MD Anderson Faculty Compensation Task Force, The University of Texas MD Anderson Cancer Center, 2019
Member, CMS Steering Committee, The University of Texas MD Anderson Cancer Center, 2019
Member, Rogers Award Selection Committee, The University of Texas MD Anderson Cancer Center, 2019
Ex-officio Member, MD/PhD Program Board, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Employee Opinion Survey Workgroup, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, UPWARDS Training Program Advisory Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Career Tracks Initiative Task Force, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Graduate School of Biomedical Sciences Executive Committee, The University of Texas MD Anderson Cancer Center UTHealth Houston, 2018 - Present
Member, Partnership for Careers in Cancer Science and Medicine Steering Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2023
Member, EndHPV Control Advisory Panel, The University of Texas MD Anderson Cancer Center, 2018 - 2020
Member, Shared Governance Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019
Member, Search Committee, Chief Technology and Digital Officer, The University of Texas MD Anderson Cancer Center, 2018
Member, Professionalism Practice Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Human Capital Management Workgroup, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Hospital Practice Committee, Models of Care: Testing Subgroup, The University of Texas MD Anderson Cancer Center, 2017 - 2020
Member, Search Committee Diagnostic Radiology Vice Chair of Education and Faculty Development, The University of Texas MD Anderson Cancer Center, 2017 - 2018
Member, Woman and Minority Faculty Inclusion Advisory Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2023
Member, Steering Committee, Rice Education in Management for Physician Trainees, 2016 - 2019
Chair, Onboarding Taskforce, The University of Texas MD Anderson Cancer Center, 2016 - 2019
Member, The University of Texas MD Anderson Cancer Center Education Collaboration Group, The University of Texas MD Anderson Cancer Center, 2015 - Present
Member, Quality Operations Team, The University of Texas MD Anderson Cancer Center, 2015 - 2019
Member, Institutional Patient Safety Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2019
Judge, 2015 Education Week Expo and Poster Competition, The University of Texas MD Anderson Cancer Center, 2015
Chair, Endowed Fellowship Awards Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Team Leader, Strategic Plan, Clinical Education Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, Simulation Center Steering Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Team Co-Leader, Strategic Plan, Training and Manpower Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, Working Group for Redesign of the Institutional Curriculum Vitae, The University of Texas MD Anderson Cancer Center, 2014 - Present
Advisor, Education Committee for Health Professions, The University of Texas MD Anderson Cancer Center, 2014 - Present
Co-Leader, Patient Handoff Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2020
Member, Cancer Network Steering Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2020
Member, Medical Quality Planning Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2019
Member, Patient Safety Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2019
Co-Chair, Training and Manpower Taskforce, Cancer Network, The University of Texas MD Anderson Cancer Center, 2014 - 2018
Member, Leaders Inspiring Vision and Excellence (LIVE), The University of Texas MD Anderson Cancer Center, 2014 - 2015
Member, Graduate Education Committee, The University of Texas MD Anderson Cancer Center, 2014
Member, Nomination Advisory Committee, Regents Outstanding Awards, The University of Texas MD Anderson Cancer Center, 2013 - Present
Co-Chair, Trainee Research Day, The University of Texas MD Anderson Cancer Center, 2013 - 2022
Member, Promotion and Tenure Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2017
Member, Executive Core Committee for the Electronic Healthcare Record, The University of Texas MD Anderson Cancer Center, 2013 - 2016
Member, CTS - Oncology Program Steering Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Member, Faculty Recognition Plan Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Member, Ad Hoc Quality Planning Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Judge, Trainee Research Day, Oral Competition Finalists, The Bristol-Myers Squibb Award in Clinical/Translational Research, The University of Texas MD Anderson Cancer Center, 2013
Ex-Officio Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Ex-Officio Member, Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2012 - Present
Member, Nocturnalist Program Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2018
Member, Education Council, The University of Texas MD Anderson Cancer Center, 2012 - 2017
Co-Chair, High-Grade Serous Ovarian Cancer and Triple-Negative Breast Cancer Moonshot Retreat Survivorship Group, The University of Texas MD Anderson Cancer Center, 2012 - 2014
Member, Search Committee, Chair of Department of Health Services Research, The University of Texas MD Anderson Cancer Center, 2012 - 2013
Judge, Trainee Research Day 2012 Poster Competition, The University of Texas MD Anderson Cancer Center, 2012
Member, Medical Education and Academic Affairs Information Systems Governance Workgroup, The University of Texas MD Anderson Cancer Center, 2011 - 2018
Member, Division of Surgery Educational Initiatives Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2013
Member, Survivorship Research Advisory Workgroup, The University of Texas MD Anderson Cancer Center, 2011 - 2013
Member, Institutional Ad Hoc Expense Analysis Steering Committee, Education Subcommittee, The University of Texas MD Anderson Cancer Center, 2011
Member, Trainee Excellence Awards Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2020
Member, Search Committee, Chair of Department of Health Services Research, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Member, Executive Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2009 - Present
Member, Patient Care Operations Team (PCOT), Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Judge, Trainee Research Day 2009 Poster Competition, The University of Texas MD Anderson Cancer Center, 2009
Member, Multidisciplinary Disposition Conference Redesign Group, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2008 - 2011
Alternate Departmental Representative, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2008 - 2011
Member, Gynecology Center Survivorship Program Project, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2008 - 2011
Member, MedAptus Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Continuing Medical Education Advisory Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Academic Affairs & Medical Education Working Group, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Search Committee, Chair of Department of Anesthesiology and Pain Medicine, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Search Committee, Chair of Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Step-Up Advisory Board, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Gynecologic Oncology Redesign Project, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2007 - 2010
Member, Education Task Force - Recognition and Reward Working Group, Meeting the Mission, The University of Texas MD Anderson Cancer Center, 2007 - 2010
Member, Advisory Committee, Interpersonal Communication and Relationship Enhancement (I*CARE), The University of Texas MD Anderson Cancer Center, 2007 - 2010
Member, Inter-Divisional Physician-Educator Working Group, The University of Texas MD Anderson Cancer Center, 2007 - 2009
Vice-Chair, Program Steering Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2007 - 2009
Member, Post-Operative Nausea and Vomiting Working Group, The University of Texas MD Anderson Cancer Center, 2007 - 2009
Ex-Officio Member, Graduate Medical Education Executive Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2009
Member, Executive Committee, Blanton-Davis Ovarian Cancer Research Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2013
Member, Fellowship Steering Committee, Hematology/Oncology Fellowship Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2012
Member, Laboratory-Based Translational Research Subcommittee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2010
Member, Gynecologic Oncology Grand Rounds Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2009
Clinic Leader, White Team, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2009
Member, Budget Taskforce, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2009
Member, Leadership Team, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2009
Member, Faculty Achievement Awards Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2008
Chair, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Member, Program Steering Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2005 - 2006
Chair, Internal Review Committee for Selective Pathology Program, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2005
Chair, Quality of Life, Health Services Research and Survivorship Working Group, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2004 - 2009
Vice-Chair, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2005
Member, Education Retreat Committee, Division of Surgery, The University of Texas MD Anderson Cancer Center, 2003 - 2004
Committee Member, 2022 Brown Foundation Award for Excellence in Oncology Nursing Selection Committee, The University of Texas MD Anderson Cancer Center, 2002 - 2022
Chair, Ethel Fleming Arceneaux Award Selection Committee, The University of Texas MD Anderson Cancer Center, 2002
Medical Director, Ovarian Cancer Support Group, The University of Texas MD Anderson Cancer Center, 2001 - 2005
Vice-Chair Elect, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2001 - 2003
Member, Ethel Fleming Arceneaux Award Selection Committee, The University of Texas MD Anderson Cancer Center, 2001
Chair, Admissions Subcommittee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2000 - 2012
Member, Clinical Operations Subcommittee, Ambulatory Clinical Building Project, The University of Texas MD Anderson Cancer Center, 2000 - 2005
Member, Credentials Committee, MD Anderson Physicians Network, The University of Texas MD Anderson Cancer Center, 2000 - 2004
Member, Institutional Review Board, The University of Texas MD Anderson Cancer Center, 2000 - 2003
Chair, Internal Review Committee for Selective Pathology Program, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2000
Member, Psychosocial, Behavioral and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 1999 - 2001
Member, Search Committee, Director of Human Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1999 - 2001
Chair, Curriculum Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1998 - 2010
Member, Trainee Recognition Day Planning Committee, The University of Texas MD Anderson Cancer Center, 1998 - 1999
Member, Medical Practice Subcommittee of the Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 1997 - 2005
Member, Budget Subcommittee of the Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 1997 - 2001
Member, MD Anderson Physicians Network Utilization Management Committee, The University of Texas MD Anderson Cancer Center, 1997 - 2001
Member, Program Review Subcommittee of the Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 1997 - 2001
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 1997 - 2001
Member, Faculty Development Committee, The University of Texas MD Anderson Cancer Center, 1997 - 2000
Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 1996 - 2012
Member, Human Clinical Cancer Genetics Group, The University of Texas MD Anderson Cancer Center, 1996 - 2005
Member, University Cancer Foundation Grant Review Committee, The University of Texas MD Anderson Cancer Center, 1996 - 1997
Editorial Activities
Guest Editor, Women's Cancer Survivorship, 2011 - 2012
Member, Editorial Board, Obstetrics and Gynecology International, 2008 - Present
Guest Editor, Breast Diseases: A Year Book Quarterly, 1999 - 2005
Honors & Awards
| 2026 | Top Doctors, Castle Connolly® |
| 2024 | Top 10% National Provider, Consumer Assessment of Healthcare Providers and Systems (CAPS) |
| 2024 | eliteTop Doctors, Castle Connolly® |
| 2023 - 2024 | Council of Deans Fellowship, American Association of Medical Colleges |
| 2023 | Top Doctors, Castle Connelly ® |
| 2020 | Excellence in LEADership Award, The University of Texas MD Anderson Cancer Center |
| 2019 - 2025 | Texas Super Doctors, Texas Monthly |
| 2019 - 2025 | Exceptional Women in Medicine, Castle Connelly ® |
| 2019 - 2025 | TX Top Doctor, TX Top Docs |
| 2019 | Top 1% of America's Most Honored Professionals, The American Registry |
| 2019 | Alpha Eta Honor Society Honorary Membership, The University of Texas MD Anderson Cancer Center |
| 2019 | Finalist Strategy Competition, Harvard Business School |
| 2018 | Awesome Job Award, The University of Texas MD Anderson Cancer Center |
| 2017 | Top Doctors, Houstonia |
| 2017 | Commitment to Mentoring Award, The University of Texas MD Anderson Cancer Center |
| 2016 | MedCity 2016 Top Doctors, Castle Connelly ® |
| 2015 | Texas Super Doctors, Texas Monthly |
| 2015 | Top Cancer Doctors, Newsweek Magazine |
| 2013 | Ashbel Smith Professor, The University of Texas MD Anderson Cancer Center |
| 2013 | Regents' Outstanding Teaching Award, The University of Texas System |
| 2013 | Educator of the Month, December, The University of Texas MD Anderson Cancer Center |
| 2013 | Women Leading the Way, August, The University of Texas MD Anderson Cancer Center |
| 2013 | Southeastern Texas Top Doctor, Castle Connolly® |
| 2012 | Women Leading the Way, November, The University of Texas MD Anderson Cancer Center |
| 2012 | Women Leading the Way, January, The University of Texas MD Anderson Cancer Center |
| 2012 | Distinguished Teaching Professor, The University of Texas System |
| 2012 | Excellence in Teaching Award, Association of Professors of Gynecology and Obstetrics |
| 2011 - 2023 | U. S. News Top Doctors, U.S. News and World Report |
| 2011 | The William Randolph Hearst Foundations Faculty Achievement Award in Education, The University of Texas MD Anderson Cancer Center |
| 2011 | International Who's Who of Professional & Business Women's Hall of Fame |
| 2010 | Association of Professors of Gynecology and Obstetrics Excellence in Teaching Award |
| 2009 - 2025 | America's Top Oncologists, Castle Connelly ® |
| 2009 | Distinguished Teaching Professor, Elected, The University of Texas Academy of Health Science Education |
| 2009 | Fellow, American Gynecological and Obstetrical Society |
| 2009 | International Who's Who of Professional & Business Women |
| 2008 - 2025 | Best Doctors in America, Castle Connolly® |
| 2008 - 2023 | Houston's Top Doctors, Houstonia |
| 2008 | Women of the Year in Medicine and Healthcare |
| 2007 | Educator of the Month, February, The University of Texas MD Anderson Cancer Center |
| 2005 - 2025 | America's Top Doctors, Castle Connolly® |
| 2005 - 2006 | Education Scholar, Association of Professors of Gynecology and Obstetrics |
| 2004 - 2023 | America's Top Obstetricians and Gynecologists |
| 2004 | Educator of the Month, May, The University of Texas MD Anderson Cancer Center |
| 2003 | Outstanding Educator, The University of Texas MD Anderson Cancer Center |
| 2002 | Fellow, American College of Surgeons, Elected |
| 2000 | Fellowship in Women's Health Policy, ACOG/Wyeth-Ayerst |
| 2000 | Finalist, Julie and Ben Rogers Award for Excellence in Education, The University of Texas MD Anderson Cancer Center |
| 1997 | Fellow, American College of Obstetricians and Gynecologists |
| 1994 | Administrative Chief Resident, The University of Alabama at Birmingham |
| 1994 | Alpha Omega Alpha, The University of Alabama at Birmingham |
| 1994 | Best Teaching Resident, The University of Alabama at Birmingham |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2018. Keynote Address. Conference. Keynote Address. Houston, TX, US.
- 2016. Discussion with Women Surgeons for Women Assistant Professors in the Division of Surgery. Invited, US.
- 2016. Transfusion Reduction Initiative in Gynecologic Oncology Achieve Project. Conference. Transfusion Reduction Initiative in Gynecologic Oncology Achieve Project. Houston, TX, US.
- 2016. 2016 Promotion and Tenure Panel. Invited. Faculty & Academic Career Enhancement. Houston, Texas, US.
- 2015. Develop Oneself. Invited. MD Anderson Group Coaching Program: Building Tomorrow's Leaders. Houston, Texas, US.
- 2015. Surgical Oncology Fellows Handoff Communication. Conference. Surgical Oncology Fellows Handoff Communication. Houston, TX, US.
- 2015. I-PASS Handoff Pilot on a Gynecologic Oncologic Service. Conference. I-PASS Handoff Pilot on a Gynecologic Oncologic Service. Houston, TX, US.
- 2015. Ensuring an Appropriate Orientation for Participants of Clinical Training Programs. Conference. Ensuring an Appropriate Orientation for Participants of Clinical Training Programs. Houston, TX, US.
- 2015. CLER: Time for Change in the Educational Environment. Conference. CLER: Time for Change in the Educational Environment. Houston, TX, US.
- 2015. Survivorship: Living Beyond Cancer. Conference. Survivorship: Living Beyond Cancer. Houston, TX, US.
- 2014. Quality Improvement for Residents and Fellows. Conference. Quality Improvement for Residents and Fellows. Houston, TX, US.
- 2014. Interprofessional Education and Teamwork in Cancer. Conference. Interprofessional Education and Teamwork in Cancer. Houston, TX, US.
- 2014. The Clinical Learning Environment - Perspectives of a DIO. Conference. The Clinical Learning Environment - Perspectives of a DIO. Houston, TX, US.
- 2011. Gynecologic Cancer Survivorship: Management of the Gynecologic Cancer Survivor. Conference. Gynecologic Cancer Survivorship: Management of the Gynecologic Cancer Survivor. Houston, TX, US.
- 2010. Health Services Research in Gynecologic Oncology and Reproductive Medicine. Conference. Health Services Research in Gynecologic Oncology and Reproductive Medicine. Houston, TX, US.
- 2000. Ovarian Cancer Update. Conference. Ovarian Cancer Update. Houston, TX, US.
- 1998. Ovarian Cancer: Current Perspectives and Future Directions. Conference. Ovarian Cancer: Current Perspectives and Future Directions. Houston, TX, US.
- 1997. Primary Care for the 90's Meeting. Conference. Primary Care for the 90's Meeting. Houston, TX, US.
- 1997. Ovarian Cancer Screening. Conference. Ovarian Cancer Screening. Houston, TX, US.
- 1996. Primary Care for the 90's Meeting. Conference. Primary Care for the 90's Meeting. Houston, TX, US.
Regional Presentations
- 2022. Improving Communication in the Hospital Medicine Department with the Implementation of a Validated Electronic Handoff Tool - I-PASS. Conference. Improving Communication in the Hospital Medicine Department with the Implementation of a Validated Electronic Handoff Tool - I-PASS. Austin, TX, US.
- 2021. Implementation of IPASS Handoff Tool in the Hospital Medicine Section at MDACC. Conference. Implementation of IPASS Handoff Tool in the Hospital Medicine Section at MDACC, US.
- 2016. The Disinfect Initiative: Decreasing the Incidence of Surgical Infections in Gynecologic Oncology. Conference. The Disinfect Initiative: Decreasing the Incidence of Surgical Infections in Gynecologic Oncology. San Antonio, TX, US.
- 2014. The SMART Program: Chemotherapy Teaching for Gynecologic Oncology Patients. Conference. The SMART Program: Chemotherapy Teaching for Gynecologic Oncology Patients. Clearwater Beach, FL, US.
- 2014. SMART chemotherapy: Improving the Patient Experience at MDACC. Conference. SMART chemotherapy: Improving the Patient Experience at MDACC. San Antonio, TX, US.
- 2014. Gynecologic Cancer Survivorship: A Shared Opportunity. Conference. Gynecologic Cancer Survivorship: A Shared Opportunity. Birmingham, AL, US.
- 2012. Development and Implementation of Pap Test Guidelines in a Gynecologic Oncology Practice. Conference. Development and Implementation of Pap Test Guidelines in a Gynecologic Oncology Practice. San Antonio, TX, US.
- 2008. Reducing the Risk of Cervical Cancer and Genital Warts in Girls and Women. Conference. Reducing the Risk of Cervical Cancer and Genital Warts in Girls and Women. San Antonio, TX, US.
- 1999. Ovarian Cancer: Advances in Screening and Detection. Conference. Ovarian Cancer: Advances in Screening and Detection. Bryan, TX, US.
National Presentations
- 2024. Reimagining the Workplace: Creating a Culture Document. Invited. 2024 Annual Leadership Conference. Nashville, TN, US.
- 2018. Smart, Strong and Bold: MD Anderson Women in Biomedical Research Career Workshop. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. An Integrated Approach to Selecting a Prepared Medical Decision Maker. Conference. An Integrated Approach to Selecting a Prepared Medical Decision Maker. San Diego, CA, US.
- 2018. Improving Patient Safety by Increasing Participation in Event Reporting Among Trainees at The University of Texas MD Anderson Cancer Center. Conference. Improving Patient Safety by Increasing Participation in Event Reporting Among Trainees at The University of Texas MD Anderson Cancer Center. Arlington, VA, US.
- 2018. Gynecologic Malignancies; What a Surgeon Wants to Know from a Radiology Report. Conference. The University of Texas MD Anderson Division of Diagnostic Imaging 1st Annual Cancer Imaging and Intervention Conference. Houston, TX, US.
- 2018. Thirving as an Academic Healthcare Institution: An Inter-professionally Developed Educators Professional Development Curriculum. Conference. 2018 Texas Academies Collaborative for the Health Professions-Southeast Educational (TEACH-S) Symposium. Houston, TX, US.
- 2017. Strong, Smart and Bold: Inspiring the Future of Biomedical Research Event. Conference. Strong, Smart and Bold: Inspiring the Future of Biomedical Research Event. Houston, TX, US.
- 2017. Fellow Remediation and Termination Society of Gynecologic Oncology Annual Meeting. Conference. Fellow Remediation and Termination Society of Gynecologic Oncology Annual Meeting. New Orleans, LA, US.
- 2015. CLER: Time for Change in the Educational Environment. Conference. Annual Global Academic Programs Conference. Houston, TX, US.
- 2015. I-PASS: Implementing a Standardized Patient Handoff Tool in a Cancer Center. Conference. Executive Leadership in Academic Medicine (ELAM) Leaders Forum. Philadelphia, PA, US.
- 2014. An Afterthought: End-of-life care documentation among ovarian cancer patients. Conference. Society of Gynecologic Oncology 45th Annual Meeting. Tampa, FL, US.
- 2014. Fighting Cancer Together: Shared Medical Appointments - A Feasibility Survey. Conference. Society of Gynecologic Oncology 45th Annual Meeting. Tampa, FL, US.
- 2014. Missed Opportunities: Patterns of Medical Care and Hospice Utilization Among Ovarian Cancer Patient. Conference. Society of Gynecologic Oncology 45th Annual Meeting. Tampa, FL, US.
- 2014. Clinical Learning Environment Review: Perspectives from a Designated Institutional Official. Conference. Accreditation Council for Graduate Medical Education (ACGME) Annual Educational Conference. National Harbor, MD, US.
- 2013. Who Will Care For Gynecologic Cancer Survivors (GynSurvivors): You Can’t Always Get What You Want, 2013 Cancer Survivorship Research Retreat, Cancer Survivorship: An Evolving Science. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2012. Quality of Life and Survivorship Issues. Conference. Ovarian Cancer: Prevention, Detection and Treatment of the Disease and Its Recurrence Conference. Pittsburg, PA, US.
- 2012. Barriers to Improving Ovarian Cancer Outcome and Survival. Conference. Ovarian Cancer: Prevention, Detection and Treatment of the Disease and Its Recurrence Conference. Pittsburg, PA, US.
- 2011. Ovarian Cancer Survivorship and Quality of Life. Conference. 2011 Women's Cancer Foundation Survivors' Course. Houston, TX, US.
- 2010. The Gynecologic Oncology Fellowship: Perspectives on the Past and Visions for the Future. Conference. 40th Annual Meeting of The Felix Rutledge Society. Chicago, IL, US.
- 2009. Ovarian Cancer Survivorship and Quality of Life. Conference. 2009 Ovarian Cancer Survivors' Course. Atlanta, GA, US.
- 2007. The Influence of Body Mass Index on Outcomes for Patients with Radical Abdominal Hysterectomy, Discussant for Plenary Session. Conference. 38th Annual Meeting of the Society of Gynecologic Oncologists. San Diego, CA, US.
- 2005. Electronic Applications for Gynecologic Oncology Fellowship, Discussant for Education Session. Conference. 36th Annual Meeting of the Society of Gynecologic Oncologists. Miami, FL, US.
- 2005. Barriers to Sexual Health after Cancer: What Should Be Done, Sunrise Session. Conference. 36th Annual Meeting of the Society of Gynecologic Oncologists. Miami, FL, US.
- 2005. Chemotherapy for Cervical and Endometrial Cancer: Controversies and Challenges. Conference. 15th Annual Meeting of the American College of Radiation Oncology. Las Vegas, NV, US.
- 2004. Genetic Risk Factors Regarding Ovarian Cancer. Conference. National Ovarian Cancer Coalition. Houston, TX, US.
- 2004. Cost-Effective Strategies For The Post-Treatment Follow-up of Gynecologic Cancer Patients, Sunset Session. Conference. 34th Annual Meeting of the Society of Gynecologic Oncologists. San Diego, CA, US.
- 2003. Update on Ovarian Cancer: What You Need to Know. Conference. 25th Annual Pharmacy Symposium on Cancer Chemotherapy. Houston, TX, US.
- 2003. Cost-Effective Strategies For The Post-Treatment Follow-up of Gynecologic Cancer Patients. Conference. 34th Annual Meeting of the Society of Gynecologic Oncologists. New Orleans, LA, US.
- 2002. Quality of Life and Patient Preference Assessments, Postgraduate Course Director. Conference. 33rd Annual Meeting of the Society of Gynecologic Oncologists. Miami Beach, FL, US.
- 2001. Gynecologic Malignancies: What Would You Like to Know?. Conference. 12th Annual Anderson Network Living Fully With Cancer Conference. Houston, TX, US.
- 2000. The Clinical Course of Low-Grade Serous Carcinomas of the Ovary. Conference. 31st Annual Meeting of The Society of Gynecologic Oncologists. San Diego, CA, US.
- 2000. Discussant for Plenary Session Prophylactic Oophorectomy (PO) in Patients at Risk for Hereditary Ovarian Carcinoma (HOS). Conference. 31st Annual Meeting of the Society of Gynecologic Oncologists. San Diego, CA, US.
- 1999. Contemporary and Innovative Approaches to Ovarian Cancer. Conference. 21st Annual Pharmacy Symposium on Cancer Chemotherapy. Houston, TX, US.
- 1999. Update on Gynecologic Cancers. Conference. 11th Annual Anderson Network Living Fully with Cancer Conference. Houston, TX, US.
- 1999. Ovarian Cancer Screening. Conference. 47th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists. Philadelphia, PA, US.
- 1999. BRCA-1 and BRCA-2: Risks and Benefits of Screening. Conference. 47th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists. Philadelphia, PA, US.
- 1999. Colposcopy Workshop. Conference. Colposcopy Workshop. Orlando, FL, US.
- 1999. Depression May Worsen Quality of Life in Patients With Ovarian Cancer. Conference. 30th Annual Meeting of The Society of Gynecologic Oncologists. San Francisco, CA, US.
- 1998. Genetic Testing for BRCA-1 and BRCA-2. Conference. 46th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists. New Orleans, LA, US.
- 1998. Ovarian Cancer Screening. Conference. 46th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists. New Orleans, LA, US.
- 1998. Clinical Guidelines and Algorithms, Sunrise Session. Conference. 29th Annual Meeting of The Society of Gynecologic Oncologists. Orlando, FL, US.
- 1997. Ovarian Cancer: Screening Prevention and Treatment. Conference. Ovarian Cancer: Screening Prevention and Treatment. Washington, US.
- 1997. Menopause and You. Conference. Menopause and You. Houston, TX, US.
- 1997. Ovarian Cancer Screening. Conference. 45th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists. Las Vegas, NV, US.
- 1997. Posttherapy Surveillance of Women with Cervical Cancer: An Outcomes Analysis. Conference. 28th Annual Meeting of The Society of Gynecologic Oncologists. Phoenix, AZ, US.
- 1996. Adult Respiratory Distress Syndrome (ARDS) in Gynecologic Oncology Patients. Conference. 27th Annual Meeting of The Felix Rutledge Society. New Orleans, LA, US.
International Presentations
- 2016. Patient - Reported Symptoms in Ovarian Cancer Before and After Disease Progression in Conjunction with Bevacizumab Maintenance Therapy. Conference. International Society of Pharmacoeconomics & Outcomes Research 21st Annual Meeting. Washington, US.
- 2016. The American Way of Life: The Gynecology Center and Gynecologic Oncology Fellowship at The University of Texas MD Anderson Cancer Center. Conference. XXV Scientific Meeting of the AGO Austria. Salzburg, AT.
- 2016. Improving Transitions of Care through Implementation of a Standardized Handoff at a Comprehensive Cancer Center. Conference. 2016 ASCO Quality of Care Symposium. Phoenix, US.
- 2015. Medical Education at MD Anderson. Conference. Taped for Medical Education Symposium. Akita, JP.
- 2015. Introduction to the University of Texas MD Anderson Cancer Center. Conference. Introduction to the University of Texas MD Anderson Cancer Center. Abu Dhabi, AE.
- 2015. Subspecialty Surgical Training Opportunities in the United States. Conference. Subspecialty Surgical Training Opportunities in the United States. Abu Dhabi, AE.
- 2015. Expert Education Panel Discussion on Residency Opportunities. Conference. Expert Education Panel Discussion on Residency Opportunities. Abu Dhabi, AE.
- 2014. Ovarian Cancer: Standards of Care and New Opportunities. Conference. 1st Qingdao International Summit Forum on Medicine. Qingdao, CN.
- 2014. SMART Chemotherapy: A Comprehensive Cancer Center's Journey to Shared Medical Appointments. Conference. 2014 ASCO Quality Care Symposium. Phoenix, US.
- 2006. Funding and Evaluation Opportunities for Fellows. Conference. The 11th Biennial Meeting of the International Gynecologic Cancer Society. Santa Monica, US.
- 2003. Quality of Life Assessment: Why It Matters. Conference. 5th Annual International Conference on Ovarian Cancer. Houston, US.
- 2003. Ovarian Cancer (OV CA): The Cost of Caregiving. Conference. 39th Annual Meeting of The American Society of Clinical Oncology. Chicago, US.
- 2002. Quality of Life Issues in Patients with Ovarian Cancer. Conference. 4th Annual International Conference on Ovarian Cancer. New York, US.
- 2001. Quality of Life and Patient Preferences: Applications in Gynecologic Oncology. Conference. 3rd Annual International Conference on Ovarian Cancer. Houston, US.
- 2001. A Phase II trial of Irinotecan (CPT-11) in Patients with Metastatic Epithelial Ovarian Cancer (EOC) or Peritoneal Cancer (PC). Conference. 37th Annual Meeting of The American Society of Clinical Oncology. San Francisco, US.
- 2000. Preferences Over Time of Women at High-Risk of Breast/Ovarian Cancer Who Undergo Genetic Counseling and Ovarian Cancer Screening. Conference. 36th Annual Meeting of The American Society of Clinical Oncology. New Orleans, US.
- 1999. Predisposition to Ovarian Cancer. Conference. Annual Meeting of The Venezuelan Oncology Society. Valencia, VE.
- 1999. Cost-Effective Work-Up and Surveillance of Cervical Cancer Patients. Conference. Annual Meeting of The Venezuelan Oncology Society. Valencia, VE.
Formal Peers
- 2022. "Quarterly Team Meeting", Panel Participant. Houston, Texas, US.
- 2022. "Education Building Presentation", Speaker, Division of Surgery. Houston, TX, US.
- 2022. "Education Building Presentation, Speaker, Quarterly Academic Leadership Team Meeting. Houston, Texas, US.
- 2021. LEADing Teams Core Opening Retreat, Speaker. Houston, Texas, US.
- 2019. "Mentorship Panel", Panel Participant, Translational Molecular Pathology Retreat. Houston, Texas, US.
- 2019. "Successful Scientists: Stories behind the CV", Panel Participant, Cancer Prevention Summer Group Session. Houston, Texas, US.
- 2019. Ovarian Cancer: Your Opportunity to ask Questions to an Expert. Visiting. Houston, TX, US.
- 2018. "Many Paths up the Mountain: Gaining Experience through Lateral Transitions," Mentoring Day Panel Participant. Houston, Texas, US.
- 2018. "Promotion on the Tenure Track", Panel Participant. Houston, Texas, US.
- 2017. "You are the CEO of your Own Career," Mentoring Day Panel Participant. Houston, TX, US.
- 2015. Improving the Patient Experience through Shared Medical Appointments, SMART Chemotherapy Education. Houston, Texas, US.
- 2012. Ovarian Cancer Survivorship. Visiting. Pittsburg, PA, US.
- 2011. Ovarian Cancer: Screening & Prevention?. Invited. Madison, WI, US.
- 2009. Reducing the Risk of Cervical Cancer and Genital Warts in Girls and Women, Grand Rounds. Invited. Ft. Worth, TX, US.
- 2009. Care of Patients with Gynecologic Malignancies: Pitfalls and Pearls. Invited. Dallas, TX, US.
- 2008. Ovarian Cancer: From Lab to Patient. Visiting. Houston, TX, US.
- 2008. Update on Ovarian Cancer: What You Need to Know. Visiting. Houston, TX, US.
- 2007. Cervical Cancer - Screening, Prevention, and Diagnosis, Grand Rounds. Invited. El Paso, TX, US.
- 2007. Latest Developments in HPV-Related Diseases and Cervical Cancer, Grand Rounds. Invited. Galveston, TX, US.
- 2006. Gynecologic Malignancies: An Update on Treatment Strategies, Grand Rounds. Invited. Atlanta, GA, US.
- 2005. Barriers to Sexual Health after Gynecologic Cancers: What Should Be Done?, Ground Rounds. Invited. Houston, TX, US.
- 2004. Chemotherapy-Induced Nausea and Vomiting (CINV): Present Challenges and Evolving Practices. Visiting. Houston, TX, US.
- 2004. Update on Ovarian Cancer: What You Need to Know. Visiting. Houston, TX, US.
- 2004. Update on Ovarian Cancer: What You Need to Know. Visiting. Houston, TX, US.
- 2004. Gynecologic Cancers: Treatment Patient Preferences and Quality of Life, Grand Rounds. Invited. Detroit, MI, US.
- 2004. Update on Ovarian Cancer: What You Need to Know. Visiting. Houston, TX, US.
- 2004. The Role of the Research Mentor. Visiting. Washington, US.
- 2004. Update on Ovarian Cancer: What You Need to Know. Visiting. Houston, TX, US.
- 2004. Update on Ovarian Cancer: What You Need to Know, Grand Rounds. Invited. Galveston, TX, US.
- 2004. Update on Ovarian Cancer: What You Need to Know. Visiting. Houston, TX, US.
- 2003. Chemotherapy-Induced Nausea and Vomiting (CINV): Present Challenges and Evolving Practices, Grand Rounds. Invited. Temple, TX, US.
- 2002. Hormone Replacement Therapy: Concepts and Controversies, Grand Rounds. Invited. Houston, TX, US.
- 2002. Novel Approaches to the Treatment of Ovarian Cancer. Visiting. Houston, TX, US.
- 2001. Hormone Replacement Therapy and Estrogen Replacement Therapy, Grand Rounds. Invited. Houston, TX, US.
- 2001. Genetic Testing: What You Should Know, Grand Rounds. Invited. Springfield, IL, US.
- 2001. Ovarian Cancer Screening. Visiting. Nashville, TN, US.
- 2000. Contemporary Treatment of Ovarian Cancer. Visiting. Houston, TX, US.
- 2000. Contemporary Treatment of Ovarian Cancer. Visiting. Houston, TX, US.
- 2000. Contemporary Treatment of Ovarian Cancer. Visiting. Houston, TX, US.
- 1999. Contemporary Treatment of Ovarian Cancer, Grand Rounds. Invited. Houston, TX, US.
- 1999. Mini-Medical School Series on Women's Health. Visiting. Houston, TX, US.
- 1999. Ovarian Cancer Update, Grand Rounds. Invited. Houston, TX, US.
- 1999. Update in Obstetrics and Gynecology, Grand Rounds. Invited. Houston, TX, US.
- 1999. Dilemmas of Genetic Testing, Grand Rounds. Invited. Miami, FL, US.
- 1998. Genetic Testing for BRCA-1 and BRCA-2, Grand Rounds. Invited. St. Charles, MO, US.
- 1998. Screening of Women at Increased Risk of Breast and Ovarian Cancer, Grand Rounds. Visiting. Houston, TX, US.
- 1998. Screening of Women at Increased Risk of Breast and Ovarian Cancer, Grand Rounds. Invited. Houston, TX, US.
- 1998. BRCA-1 and BRCA-2: The Dilemmas of Genetic Testing, Grand Rounds. Invited. St. Louis, MO, US.
- 1998. BRCA-1 and BRCA-2: The Dilemmas of Genetic Testing, Grand Rounds. Invited. Charlottesville, VA, US.
- 1997. Evaluation of the Abnormal Pap Smear, Grand Rounds. Visiting. Humble, TX, US.
- 1997. Evaluation of the Abnormal Pap Smear, Grand Rounds. Invited. Humble, TX, US.
- 1997. Chemotherapy and Gynecologic Malignancies, Grand Rounds. Invited. Chattanooga, TN, US.
- 1996. Endometrial Cancer: Current Concepts, Grand Rounds. Invited. Abilene, TX, US.
Grant & Contract Support
| Date: | 2021 - 2027 |
| Title: | MD Anderson Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program |
| Funding Source: | NIH/NCI |
| Role: | Co-Lead |
| ID: | 1U54CA267667-01 |
| Date: | 2020 - 2022 |
| Title: | School of Health Professions CARES Act Funding |
| Funding Source: | US Department of Education |
| Role: | PI |
| ID: | P425F202276 |
| Date: | 2019 - 2022 |
| Title: | NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Date: | 2019 - 2024 |
| Title: | University of Texas MD Anderson Cancer Center Support Grant: Cancer Research Career Enhancement and Related Activities; Leadership, Planning, and Evaluation Core Component |
| Funding Source: | NIH/NCI |
| Role: | CRCE Co-Director |
| ID: | CA016672-44 |
| Date: | 2019 - 2022 |
| Title: | Mike Hogg Award and Lecture Fund |
| Funding Source: | Mike Hogg Fund |
| Role: | PI |
| Date: | 2015 - 2016 |
| Title: | SMART |
| Funding Source: | MD Anderson |
| Role: | Program Leader |
| ID: | QIB-6009 |
| Date: | 2015 - 2016 |
| Title: | Innovations in GME |
| Funding Source: | Josiah Macy Jr Foundation |
| Role: | Program Chair |
| Date: | 2013 - 2015 |
| Title: | Preferences of Gynecologic Cancer Survivors and General Gynecologists for Follow-up Care after Cancer |
| Funding Source: | UT MDACC |
| Role: | PI |
| ID: | PA12-0950 |
| Date: | 2012 - 2013 |
| Title: | MD Anderson Symptom Inventory - Ovarian Cancer: Development and Validation in Patients with Ovarian Cancer |
| Funding Source: | Genentech |
| Role: | Collaborator |
| ID: | CS2011-00035244JW |
| Date: | 2011 - 2016 |
| Title: | Multidisciplinary Subspecialty Pathology Research Fellowship Program |
| Funding Source: | NIH/DHHS |
| Role: | Internal Advisory Board |
| ID: | T32CA163185-01 |
| Date: | 2011 - 2016 |
| Title: | Training of Academic Gynecologic Oncologists |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 2T32CA101642-06 A1 |
| Date: | 2010 - 2016 |
| Title: | Specialized Program of Research Excellence in Uterine Cancer Career Development Award |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | 5P50CA098258-09 |
| Date: | 2010 - 2011 |
| Title: | A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy versus Placebo in Women Who Have Not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
| Funding Source: | GlaxoSmithKline |
| Role: | PI |
| Date: | 2008 - 2011 |
| Title: | A Phase II, Non-Randomized, Open-label, Multicenter Study of IMC-1121B in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal |
| Funding Source: | Imclone Systems |
| Role: | PI |
| Date: | 2008 - 2012 |
| Title: | Multi-Institutional Ovarian Cancer Outcomes Project within the National Comprehensive Cancer Network |
| Funding Source: | National Comprehensive Cancer Network |
| Role: | Co-I |
| ID: | DR08-0355 |
| Date: | 2007 - 2009 |
| Title: | Specialized Program of Research Excellence in Uterine Cancer Career Development Award |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | P50 CA098258-05 |
| Date: | 2005 - 2010 |
| Title: | T32 Training of Academic Gynecologic Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | T32 CA101642 |
| Date: | 2005 - 2010 |
| Title: | WRHR Program |
| Funding Source: | Baylor College of Medicine |
| Role: | Mentor |
| ID: | K12 05-0128-01 |
| Date: | 2004 - 2009 |
| Title: | Social Cognitive Theory and Physical Activity after Endometrial Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5-R09-CA109919-03 |
| Date: | 2003 - 2022 |
| Title: | MD Anderson Gynecologic SPORE for Uterine Cancers; Career Enhancement Program |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | CA098258-13 |
| Date: | 2003 - 2008 |
| Title: | Career Development Core |
| Funding Source: | MD Anderson Cancer Gynecologic SPORE for Uterine Cancer |
| Role: | Consult |
| ID: | 1 P50 CA098258 |
| Date: | 2003 - 2008 |
| Title: | NO TITLE PROVIDED |
| Funding Source: | MD Anderson Cancer Gynecologic SPORE for Uterine Cancer |
| Role: | Co-I |
| ID: | 1 P50 CA098258 |
| Date: | 2003 - 2008 |
| Title: | Depression Screening and Treatment in Ovarian Cancer |
| Funding Source: | NCI |
| Role: | Co-I |
| ID: | 1 KO7 CA093512 |
| Date: | 2003 - 2006 |
| Title: | Sexual Functioning and Quality Of Life in Women with Cervical Cancer |
| Funding Source: | NIH |
| Role: | PI |
| ID: | 1R03CA097869-1 |
| Date: | 2002 - 2005 |
| Title: | A Phase II Study of Irofulven (IND #48914) in Patients with Refractory or Recurrent Advanced Epithelial Ovarian Cancer Using Every-Other-Week Dosing |
| Funding Source: | MGI Pharma |
| Role: | PI |
| ID: | GYN01-486 |
| Date: | 2002 - 2004 |
| Title: | Chemotherapy-Related Toxicities in Ovarian Cancer Patients: Preference Assessments of Patients |
| Funding Source: | Blanton-Davis Ovarian Cancer Research Program Research Award |
| Role: | PI |
| Date: | 2000 - 2013 |
| Title: | The Elizabeth Registry for the Study of Low-Grade Serous Ovarian Carcinoma |
| Funding Source: | The Elizabeth Fund, Private Philanthropic Funds |
| Role: | PI |
| Date: | 2000 - 2004 |
| Title: | Unrestricted Grant for Quality of Life and Patient Preferences Research |
| Funding Source: | Merck and Company |
| Role: | Investigator |
| Date: | 2000 - 2004 |
| Title: | Modulation of Putative Surrogate End-point BioMarkers in Endometrial Biopsies from Women with HNPCC |
| Funding Source: | NCI/DCP |
| Role: | Co-I |
| ID: | N01-CN-05127 |
| Date: | 2000 - 2002 |
| Title: | Perceptions of Taxol-Carboplatin Toxicity and Quality of Life Among Ovarian Cancer Patients |
| Funding Source: | Texas Federation of Business and Professional Women |
| Role: | PI |
| Date: | 2000 - 2002 |
| Title: | Identifying Factors Associated with Early Detection of Ovarian Cancer |
| Funding Source: | National Center for Chronic Disease Prevention & Health Promotion Centers for Disease Control and Prevention |
| Role: | Co-I |
| ID: | U48/CCU609653-08 SIP 15-00 |
| Date: | 1999 - 2012 |
| Title: | Study of Women at Increased Risk of Breast and Ovarian Cancer |
| Funding Source: | The Ellwood Foundation |
| Role: | PI |
| Date: | 1999 - 2007 |
| Title: | Evaluating Patient Preferences Quality of Life and Symptoms of Treatment in Ovarian Cancer Patients Receiving High Dose and Standard Chemotherapy |
| Funding Source: | PRS Institutional Research Grant |
| Role: | PI |
| ID: | ID99-272 |
| Date: | 1999 - 2004 |
| Title: | The National Ovarian Cancer Early Detection Program |
| Funding Source: | NCI |
| Role: | Co-I |
| ID: | 1 U01 CA85133-01/NIH/NCI RFA CA98-028 |
| Date: | 1999 - 2004 |
| Title: | Specialized Program of Research Excellence in Ovarian Cancer |
| Funding Source: | NIH |
| Role: | Collaborator |
| ID: | IP50 CA83639 |
| Date: | 1999 - 2000 |
| Title: | Chemoprevention of Ovarian Cancer |
| Funding Source: | U.S. Army (DOD) |
| Role: | Investigator |
| ID: | DAMD17-99-1-9505 (PP-2)-1 |
| Date: | 1998 - 2003 |
| Title: | Prophylactic Mastectomy and Oophorectomy for Women at Risk of Breast and Ovarian Cancer: Incorporating Preferences in a Decision Analysis |
| Funding Source: | PRS Institutional Research Grant |
| Role: | PI |
| ID: | ID98-053 |
Selected Publications
Peer-Reviewed Articles
- Ait Aiss, M, Vesho, D, Bowe, C, Franco Vega, M, Chau, S, Beno, J, George, MC, Porter, C, Bodurka, DC. Using I-PASS to improve nursing handoffs across the continuum of care at a tertiary oncology hospital. BMJ Open Quality 14(3), 2025. e-Pub 2025. PMID: 40992774.
- Amaram-Davila, JS, Vega, MF, Bramati, PS, Stewart, HA, Aceves, M, Dalal, S, Reddy, AS, Azhar, A, Reddy, SK, Bodurka, DC, George, MC, Aiss, MA, Bruera, E. From Emails to EMR. Cancers 17(17), 2025. e-Pub 2025. PMID: 40940972.
- Undie, W, Bodurka, DC, Miller, D, Hoggatt Krumwiede, KA, Benamar, A, Tannir, H, Hu, P. Partnering Academic and Clinical Operations to Build a Sustainable Allied Health Workforce The University of Texas MD Anderson Cancer Center Experience. Journal of allied health 54(2):e199-e204, 2025. e-Pub 2025. PMID: 40493938.
- Franco Vega, M, Ait Aiss, M, George, MC, Day, L, Mbadugha, A, Owens, K, Sweeney, C, Chau, S, Escalante, CP, Bodurka, DC. Enhancing Implementation of the I-PASS Handoff Tool Using a Provider Handoff Task Force at a Comprehensive Cancer Center. Joint Commission Journal on Quality and Patient Safety 50(8):560-568, 2024. e-Pub 2024. PMID: 38584053.
- Franco Vega MC, Ait Aiss M, Smith M, George M, Day L, Mbadugha A, Niangar Z, Bodurka DC. Improving handoff with the implementation of I-PASS at a tertiary oncology hospital. BMJ Open Qual 12(4), 2023. e-Pub 2023. PMID: 37802542.
- Prescott LS, Vergote I, Sun CC, Bodurka DC, Coleman RL. Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort. Int J Gynecol Cancer 33(1):1-9, 2023. e-Pub 2023. PMID: 36356982.
- Hinchcliff E, Gunther J, Ponnie AE, Bednarski B, Onstad M, Shafer A, Frumovitz M, Jazaeri A, Urbauer D, Bodurka DC. A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs. J Cancer Educ 37(3):615-620, 2022. e-Pub 2022. PMID: 32839894.
- Zhukovsky DS, Haider A, Williams JL, Naqvi S, Joshi N, Mills S, Soliman PT, Mathew B, Bodurka DC, Meyer LA, Westin S, Frumovitz M, Nowitz MB, Archie L, Fenton S, Lang K, Boving V, Bruera E. An Integrated Approach to Selecting a Prepared Medical Decision Maker. J Pain Symptom Manage 61(6):1305-1310, 2021. e-Pub 2021. PMID: 33348030.
- Coleman RL, Hu W, Soliman P, Nick A, Ramirez PT, Westin SN, Garcia ME, Zhu Z, Palancia J, Fellman BM, Yuan Y, Ram P, Bischoff F, Schmeler K, Bodurka DC, Meyer LA, Sood AK. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecol Oncol 161(1):104-112, 2021. e-Pub 2021. PMID: 33551196.
- Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, Urbauer DL, Ramondetta LM, Schmeler KM, Soliman PT, Fleming ND, Burzawa JK, Nick AM, Milbourne AM, Yuan Y, Lu KH, Bodurka DC, Coleman RL, Yates MS. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. Am J Obstet Gynecol 224(2):191.e1-191.e15, 2021. e-Pub 2021. PMID: 32805208.
- Bailey CD, Previs R, Fellman BM, Zaid T, Huang M, Brown A, Enbaya A, Balakrishnan N, Broaddus RR, Bodurka DC, Soliman P, Fleming ND, Nick A, Sood AK, Westin SN. Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer. Int J Gynecol Cancer 31(2):232-237, 2021. e-Pub 2021. PMID: 33122243.
- Chelariu-Raicu A, Levenback C, Slomovitz B, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson D, Coleman R. Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer. Int J Gynecol Cancer, 2020. e-Pub 2020. PMID: 33037105.
- Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka DC, DePombo A, Lee HJ, de Groot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020. PMID: 32484922.
- Zhukovsky DS, Soliman PT, Mathew B, Mills S, Bodurka DC, Frumovitz M, Meyer LA, Westin S, Nowitz M, Archie L, Fenton S, Lang K, Williams JL, Boving V, Bruera E. Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract 15(12):JOP1900109, 2019. e-Pub 2019. PMID: 31613720.
- Prescott LS, Taylor JS, Enbaya A, Marten CA, Myers KN, Meyer LA, Ramirez PT, Levenback CF, Bodurka DC, Schmeler KM. Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol 153(3):597-603, 2019. e-Pub 2019. PMID: 30872025.
- Polansky MN, Govaerts MJB, Stalmeijer RE, Eid A, Bodurka DC, DHJM D. Exploring the effect of PAs on physician trainee learning: An interview study. JAAPA 32(5):47-53, 2019. e-Pub 2019. PMID: 31033715.
- Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol 152(3):452-458, 2019. e-Pub 2019. PMID: 30876488.
- Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK. Women's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol 152(3):514-521, 2019. e-Pub 2019. PMID: 30876497.
- Olawaiye AB, Java JJ, Krivak TC, Friedlander M, Mutch DG, Glaser G, Geller M, O'Malley DM, Wenham RM, Lee RB, Bodurka DC, Herzog TJ, Bookman MA. Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23]. Gynecol Oncol 152(1):220, 2019. e-Pub 2019. PMID: 30360899.
- Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Am J Med Qual 33(6):629-636, 2018. e-Pub 2018. PMID: 29779398.
- Olawaiye AB, Java JJ, Krivak TC, Friedlander M, Mutch DG, Glaser G, Geller M, O'Malley DM, Wenham RM, Lee RB, Bodurka DC, Herzog TJ, Bookman MA. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol 151(1):18-23, 2018. e-Pub 2018. PMID: 30135020.
- Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective Assessment of Patient - Reported Outcomes in Gynecologic Cancer Patients Before and After Pelvic Exenteration. Gynecol Oncol 149(3):484-490, 2018. e-Pub 2018. PMID: 29622276.
- Schlumbrecht M, Sun C, Huang M, Milbourne A, Bodurka DC. Gynecologic Cancer Survivor Preferences for Long-Term Surveillance. BMC Cancer 18(1):375, 2018. e-Pub 2018. PMID: 29614979.
- Shah JS, Guerra R, Bodurka DC, Sun CC, Chisholm GB, Woodard TL. Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members. Gynecol Oncol 147(3):497-502, 2017. e-Pub 2017. PMID: 28941656.
- Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer, 2017. e-Pub 2017. PMID: 28574929.
- Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM. Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients. Support Care Cancer 25(6):1985-1991, 2017. e-Pub 2017. PMID: 28175997.
- Shinn EH, Valentine A, Baum G, Carmack C, Kilgore K, Bodurka DC, Basen-Engquist K. Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints. Gynecol Oncol 145(3):562-568, 2017. e-Pub 2017. PMID: 28400146.
- Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol 35(16):JCO2016702894, 2017. e-Pub 2017. PMID: 28388292.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DC. The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients. Int J Gynecol Cancer 27(4):838-846, 2017. e-Pub 2017. PMID: 28399031.
- Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibber JM, Aloia TA. Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. Surgery 161(3):869-875, 2017. e-Pub 2017. PMID: 27825699.
- Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM. The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol 24(2):362-368, 2017. e-Pub 2017. PMID: 27573526.
- Julius JM, Hammerstrom A, Wei C, Rajesh R, Bodurka DC, Kurian S, Smith JA. Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies. J Oncol Pharm Pract, 2017. e-Pub 2015. PMID: 26692242.
- Taylor JS, Marten CA, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KM. What Is the Real Rate of Surgical Site Infection?. J Oncol Pract 12(10):e878-e883, 2016. e-Pub 2016. PMID: 27460495.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka DC. Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients. Gynecol Oncol 142(3):525-30, 2016. e-Pub 2016. PMID: 27439968.
- Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv 10(2):261-70, 2016. e-Pub 2016. PMID: 26245979.
- Taylor JS, Brown AJ, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. Dying well: How equal is end of life care among gynecologic oncology patients?. Gynecol Oncol 140(2):295-300, 2016. e-Pub 2016. PMID: 26706661.
- Prescott LS, Dickens AS, Guerra SL, Tanha JM, Phillips DG, Patel KT, Umberson KM, Lozano MA, Lowe KB, Brown AJ, Taylor JS, Soliman PT, Garcia EA, Levenback CF, Bodurka DC. Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education. Gynecol Oncol 140(1):114-9, 2016. e-Pub 2016. PMID: 26549108.
- Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LM. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecol Oncol 139(3):553-8, 2015. e-Pub 2015. PMID: 26432043.
- Taylor JS, Brown AJ, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. Dying well: How equal is end of life care among gynecologic oncology patients?. Gynecol Oncol 140(2):295-300, 2015. e-Pub 2015. PMID: 26706661.
- Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecologic Oncology 139(3):553-558, 2015. e-Pub 2015. PMID: 26432043.
- Gershenson DM, Bodurka DC, Lu KH, Nathan LC, Milojevic L, Wong KK, Malpica A, Sun CC. Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor. J Clin Oncol 33(24):2675-82, 2015. e-Pub 2015. PMID: 26195696.
- Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM. Targeting those with decreased meaning and peace: A supportive care opportunity. Support Care Cancer 23(7):2025-32, 2015. e-Pub 2015. PMID: 25519758.
- Brown AJ, Sun CC, Urbauerb DL, Bodurka DC, Thaker PH, Ramondetta LM. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients. Gynecol Oncol 138(suppl 2):388-393, 2015. e-Pub 2015. PMID: 25988961.
- Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DC. Perioperative blood transfusion in gynecologic oncology surgery: Analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol 136(1):65-70, 2015. e-Pub 2015. PMID: 25451693.
- Chi G, Young A, McFarlane J, Watson M, Coleman R, Eifel P, LoBiondo-Wood G, Bodurka DC, Richardson M. Effects of music relaxation video on pain and anxiety for women with gynaecological cancer receiving intracavitary brachytherapy: a randomised controlled trial. J Res Nurs 20(2):129-144, 2015. e-Pub 2015.
- Brown AJ, Sun CC, Prescott LS, Taylor JS, Ramondetta LM, Bodurka DC. Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients. Gynecol Oncol 135(2):244-8, 2014. e-Pub 2014. PMID: 25192878.
- Brown AJ, Shen MJ, Ramondetta LM, Bodurka DC, Giuntoli RL, Diaz-Montes T. Does Death Anxiety Affect End-of-Life Care Discussions?. Int J Gynecol Cancer 24(8):1521-6, 2014. e-Pub 2014. PMID: 25188890.
- Penson RT, Moore KM, Fleming GF, Braly P, Schimp V, Nguyen H, Matulonis UA, Banerjee S, Haluska P, Gore M, Bodurka DC, Hozak RR, Joshi A, Xu Y, Schwartz JD, McGuire WP. A Phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma. Gynecol Oncol 134(pii: S0090-8258(14)01070-1):478-85, 2014. e-Pub 2014. PMID: 25016924.
- Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol 134(3):546-51, 2014. e-Pub 2014. PMID: 25014540.
- Sun C, Brown AJ, Jhingran A, Frumovitz M, Ramondetta L, Bodurka DC. Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer 24(6):1077-84, 2014. e-Pub 2014. PMID: 24905618.
- Hou MM, Liu X, Wheler J, Naing A, Hong D, Bodurka DC, Schmeler K, Tsimberidou A, Janku F, Zinner R, Piha-Paul S, Hu CY, Lu K, Kurzrock R, Fu S. Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program. Anticancer Res 34(5):2349-55, 2014. e-Pub 2014. PMID: 24778042.
- Schlumbrecht MP, Sun CC, Huang MS, Zandstra F, Bodurka DC. Lifestyle modification in cervical cancer survivors: an ongoing need. Int J Gynecol Cancer 24(IGC-D-13-00560R1):570-5, 2014. e-Pub 2014. PMID: 24469324.
- Holman LL, Lu KH, Bast RC, Hernandez MA, Bodurka DC, Skates S, Sun CC. Risk Perception, Worry, and Test Acceptance in Average-Risk Women Undergoing Ovarian Cancer Screening. Am J Obstet Gynecol 210(3):257.e1-6, 2014. e-Pub 2014. PMID: 24246524.
- Zaid T, Burzawa J, Basen-Engquist K, Bodurka DC, Ramondetta LM, Brown J, Frumovitz M. Use of Social Media to Conduct a Cross-Sectional Epidemiologic and Quality of Life Survey of Patients with Neuroendocrine Carcinoma of the Cervix: A Feasibility Study. Gynecol Oncol 132(1):149-53, 2014. e-Pub 2014. PMID: 24145111.
- Williams LA, Agarwal S, Bodurka DC, Saleeba AK, Sun CC, Cleeland CS. Capturing the patient's experience: Using qualitative methods to develop a measure of patient-reported symptom burden: An example from ovarian cancer. J Pain Symptom Manage 46(6):837-45, 2013. e-Pub 2013. PMID: 23615044.
- Basen-Engquist K, Carmack CL, Li Y, Brown J, Jhingran A, Hughes DC, Perkins HY, Scruggs S, Harrison C, Baum G, Bodurka DC, Waters A. Social cognitive theory predictors of exercise behavior in endometrial cancer survivors. Health Psychol 32(11):1137-48, 2013. e-Pub 2013. PMID: 23437853.
- Likhacheva A, Jhingran A, Bodurka DC, Sun C, Sam M, Eifel PJ. Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly cisplatin or every-3-week cisplatin and 5-fluorouracil. Int J Gynecol Cancer 23(8):1520-7, 2013. e-Pub 2013. PMID: 24257567.
- Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS. Validating the MD Anderson symptom inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol 130(2):323-8, 2013. e-Pub 2013. PMID: 23685012.
- Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIa (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol 129(2):304-9, 2013. e-Pub 2013. PMID: 23385150.
- Iglesias DA, Bodurka DC. Personalized care in uterine cancer. Clin Adv Hematol 10(12):797-805, 2012. e-Pub 2012. PMID: 23271352.
- Gershenson D, Sun C, Iyer R, Malpica A, Kavanagh J, Bodurka DC, Schmeler K. Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol 125(3):661-6, 2012. e-Pub 2012. PMID: 22406638.
- Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, Lu KH, Sood AK, Birrer MJ, Ozols R, Baergen R, Emerson RE, Steinhoff M, Behmaram B, Rasty G, Gershenson DM. Reclassification of serous ovarian carcinoma by a 2-tier system: A Gynecologic Oncology Group Study. Cancer 118(1):3087-94, 2012. e-Pub 2012. PMID: 22072418.
- Frumovitz M, Kriseman, M, Sun C, Blumenthal-Barby J, Sood A, Bodurka DC, Soliman P. Unverifiable accomplishments and publications on applications for gynecologic oncology fellowships. Obstet Gynecol 119(3):504-8, 2012. e-Pub 2012. PMID: 22353948.
- Moroney JW, Schlumbrecht MP, Helgason T, Coleman RL, Moulder S, Naing A, Bodurka DC, Janku F, Hong DS, Kurzrock R. A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies. Clin Cancer Res 17(21):6840-6, 2011. e-Pub 2011. PMID: 21890452.
- Schlumbrecht MP, Sun CC, Wong KN, Broaddus RR, Gershenson DM, Bodurka DC. Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma. Cancer 117(16):3741-49, 2011. e-Pub 2011. PMID: 21319148.
- Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, Lacour RA, Johnson KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC. Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer 117(12):2659-67, 2011. e-Pub 2011. PMID: 21656744.
- Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershenson DM. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol 121(3):482-486, 2011. e-Pub 2011. PMID: 21397305.
- Heyman KP, Worley MJ, Frey MK, Kessler RT, Bodurka DC, Slomovitz BM. Willingness of pregnant women to vaccinate themselves and their newborns with the HPV vaccine. Vaccine 29(28):4618-22, 2011. e-Pub 2011. PMID: 21557976.
- Lacour RA, Westin SN, Meyer LA, Wingo SN, Schorge JO, Brooks R, Mutch D, Molina A, Sutphen R, Barnes M, Elder J, Teoh D, Powell CB, Choubey V, Blank S, Macdonald HR, Brady MF, Urbauer DL, Bodurka DC, Gershenson DM, Lu KH. Improved survival in non-ashkenazi jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecol Oncol 121(2):358-63, 2011. e-Pub 2011. PMID: 21276604.
- Schlumbrecht MP, Gallagher CM, Sun CC, Ramondetta LM, Bodurka DC. Ethics consultation on a gynecologic oncology service: An opportunity for physician education. J Cancer Educ 26(1):183-7, 2011. e-Pub 2011. PMID: 20835927.
- Vineyard MA, Daniels MS, Urbauer DL, Deavers MT, Sun CC, Boerwinkle E, Bodurka DC, Gershenson DM, Crawford J, Lu KH. Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?. Gynecol Oncol 120(2):229-32, 2011. e-Pub 2011. PMID: 21126756.
- Bodurka DC, Huang M, Sun CC. Caring for cancer patients in the future: A perfect storm on the horizon?. Oncology 24(14):1351-2, 2010. e-Pub 2010. PMID: 21294483.
- Agarwal S, Bodurka DC. Symptom research in gynecologic oncology - A review of available measurement tools. Gynecol Oncol 119(2):384-9, 2010. e-Pub 2010. PMID: 20688364.
- Raghunath A, Adamus G, Bodurka DC, Liu J, Schiffman J. Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube. J Neuroophthalmol 30(3):252-4, 2010. e-Pub 2010. PMID: 20724944.
- Moroney J, Wheler J, Hong D, Naing A, Falchook G, Bodurka DC, Coleman R, Lu K, Xiao L, Kurzrock R. Phase I clinical trials in 85 patients with gynecologic cancer: The MD Anderson Cancer Center experience. Gynecol Oncol 117(3):467-72, 2010. e-Pub 2010. PMID: 20347123.
- Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: Implications for Survivors. Cancer 116(3):625-630, 2010. e-Pub 2010. PMID: 20052724.
- Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DC. Survival after intestinal perforation: Can it be predicted?. Gynecol Oncol 115(3):349-53, 2009. e-Pub 2009. PMID: 19765809.
- Shinn EH, Taylor CL, Kilgore K, Valentine A, Bodurka DC, Kavanagh J, Sood A, Li Y, Basen-Engquist K. Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients. Palliat Support Care 7(3):299-306, 2009. e-Pub 2009. PMID: 19788771.
- Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: Does marital status matter?. Int J Gynecol Cancer 19(6):1107-1112, 2009. e-Pub 2009. PMID: 19820377.
- Gershenson DM, Sun CC, Bodurka DC, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJ. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecol Oncol 114(1):48-52, 2009. e-Pub 2009. PMID: 19361839.
- Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: A retrospective analysis. Gynecol Oncol 113(3):324-6, 2009. e-Pub 2009. PMID: 19342083.
- Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK. Perception of screening and risk-reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer 115(8):1598-604, 2009. e-Pub 2009. PMID: 19280625.
- Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: Associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200(3):288.e1-e8, 2009. e-Pub 2009. PMID: 19110220.
- Hunter RJ, Navo MA, Thaker PH, Bodurka DC, Wolf JK, Smith JA. Dosing chemotherapy in obese patients: Actual versus assigned body surface area (BSA). Cancer Treat Rev 35(1)(1):69-78, 2009. e-Pub 2009. PMID: 18922643.
- Guntupalli S, Anderson ML, Bodurka DC. Alveolar soft part sarcoma of the cervix: A case report and literature review. Arch Gynecol Obstet 279(2):263-5, 2009. e-Pub 2009. PMID: 18548261.
- Westin SN, Lacour RA, Urbauer DL, Luthra R, Bodurka DC, Lu KH, Broaddus RR. Carcinoma of the lower uterine segment: A newly described association with Lynch Syndrome. J Clin Oncol 26(36):5965-71, 2008. e-Pub 2008. PMID: 19001318.
- Frumovitz M, Soliman PT, Greer M, Schmeler KM, Moroney J, Bodurka DC, Ramirez PT. Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol 111(2)(2):197-201, 2008. e-Pub 2008. PMID: 18804849.
- Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM, Tsang YT, Armaiz-Pena GN, Lu C, Kamat AA, Han LY, Spannuth WA, Nick AM, Landen CN, Wong KK, Gray MJ, Coleman RL, Bodurka DC, Brinkley WR, Sood AK. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res 14(17):5437-46, 2008. e-Pub 2008. PMID: 18765535.
- Miller DS, Blessing JA, Bodurka DC, Bonebrake AJ, Schorge JO. Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group. Gynecol Oncol 110(1):65-70, 2008. e-Pub 2008. PMID: 18455781.
- Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment and survival among older women with epithelial ovarian cancer. Int J Gynecol Cancer 18(4):660-669, 2008. e-Pub 2008. PMID: 17892451.
- Batista LI, Lu KH, Beahm EK, Arun BK, Bodurka DC, Meric-Bernstam F. Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome. BMC Cancer 8:101, 2008. e-Pub 2008. PMID: 18410690.
- Schmeler KM, Sun CC, Bodurka DC, Deavers MT, Malpica A, Coleman RL, Ramirez PT, Gershenson DM. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol 108(3):510-4, 2008. e-Pub 2008. PMID: 18155273.
- Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 70(1)(1):118-25, 2008. e-Pub 2008. PMID: 17869451.
- Anderson ML, Bodurka DC. Thoracotomy for the management of recurrent vaginal leiomyosarcoma. Int J Gynecol Cancer 18(1)(1):188-190, 2008. e-Pub 2008. PMID: 17506839.
- Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis. Int J Gynecol Pathol 26(4)(4):404-409, 2007. e-Pub 2007. PMID: 17885490.
- Tung CS, Soliman PT, Wallace MJ, Wolf JK, Bodurka DC. Successful catheter-directed venous thrombolysis in phlegmasia cerulea dolens. Gynecol Oncol 107(1)(1):140-153, 2007. e-Pub 2007. PMID: 17669477.
- Landen CN, Lin YG, Immaneni A, Deavers MT, Merritt WM, Spannuth WA, Bodurka DC, Gershenson DM, Brinkley WR, Sood AK. Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin Cancer Res 13(14)(14):2098-2104, 2007. e-Pub 2007. PMID: 17634535.
- Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DM. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma. Gynecol Oncol 105(3):625-9, 2007. e-Pub 2007. PMID: 17320156.
- Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol (105)2(2):470-474, 2007. e-Pub 2007. PMID: 17292459.
- Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 104(1):100-3, 2007. e-Pub 2007. PMID: 16963111.
- Niederhauser A, West LA, Magann E, Bodurka DC. Tubo-ovarian abscess following small bowel perforation caused by Entamoeba histolytica. Pelv Med Surg 13(1):27-28, 2007. e-Pub 2007.
- Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC. Are women ready for the HPV vaccine?. Gynecol Oncol 103(1)(1):151-4, 2006. e-Pub 2006. PMID: 16551476.
- Wolf JK, Bodurka DC, Verschraegen C, Sun CC, Branham D, Jenkins AD, Atkinson N, Gershenson DM. A phase II trial of oral capecitabine in patients with platinum- and taxane-refractory ovarian, fallopian tube, or peritoneal cancer. Gynecol Oncol 102(3):468-74, 2006. e-Pub 2006. PMID: 16516276.
- Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol 108(3 Pt 1):515-20, 2006. e-Pub 2006. PMID: 16946209.
- Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DC. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol 108(2):361-8, 2006. e-Pub 2006. PMID: 16880307.
- Elting LS, Cooksley C, Bekele BN, Frumovitz M, Avritscher EB, Sun C, Bodurka DC. Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants. Cancer 106(11):2452-8, 2006. e-Pub 2006. PMID: 16639738.
- Seiden MV, Gordon AN, Bodurka DC, Matulonis UA, Penson RT, Reed E, Alberts DS, Weems G, Cullen M, McGuire WP. A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. Gynecol Oncol 101(1):55-61, 2006. e-Pub 2006. PMID: 16260029.
- Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecol Oncol 101(1):126-31, 2006. e-Pub 2006. PMID: 16271384.
- Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, Warren JL. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 98(3):172-80, 2006. e-Pub 2006. PMID: 16449677.
- Silva EG, Deavers MT, Bodurka DC, Malpica A. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: A new type of dedifferentiated carcinoma?. Int J Gynecol Pathol 25(1):52-8, 2006. e-Pub 2006. PMID: 16306785.
- Cheng YC, Saliba RM, Rondón G, Giralt SA, Lu KH, Bodurka DC, Gershenson DM, Champlin RE, Ueno NT. Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation. Haematologica 90(12):1725-6, 2005. e-Pub 2005. PMID: 16330461.
- Ramirez PT, Sun CC, Vidal CI, Schimp V, Slomovitz BM, Bevers MW, Bodurka DC. Outcomes of hysteroscopy and hysterectomy in breast cancer patients. Cancer Ther 3:147-152, 2005. e-Pub 2005.
- Altrabulsi B, Malpica A, Deavers MT, Bodurka DC, Broaddus R, Silva EG. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol 29(10):1316-21, 2005. e-Pub 2005. PMID: 16160474.
- Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703-20, 2005. e-Pub 2005. PMID: 16157938.
- Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428-36, 2005. e-Pub 2005. PMID: 16234510.
- Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 97(3):840-4, 2005. e-Pub 2005. PMID: 15882895.
- Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubenstein EB. Rankings and symptom assessments of side effects from chemotherapy: Insights from experienced patients with ovarian cancer. Support Care Cancer 13(4):219-27, 2005. e-Pub 2005. PMID: 15538640.
- Silva EG, Bodurka DC, Scouros MA, Ayala A. A uterine leiomyosarcoma that became positive for HMB45 in the metastasis. Ann Diagn Pathol 9(1):43-5, 2005. e-Pub 2005. PMID: 15692950.
- Cloutier L, Kurian S, Bodurka DC, Dejesus Y. Use of clinical pathways and patient care calendar to enhance patient education and participation. J Gynecol Oncol Nursing 14:577-583, 2004. e-Pub 2004. PMID: 28561657.
- Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95(3):463-8, 2004. e-Pub 2004. PMID: 15581947.
- Frumovitz M, Slomovitz BM, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Endometrial Cancer: To stage or not to stage?. J Amer Coll Surg 199:388-393, 2004. e-Pub 2004. PMID: 15325608.
- Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg 199(3):388-93, 2004. e-Pub 2004. PMID: 15325608.
- Frumovitz M, Ramirez PT, Greer M, Gregurich MA, Wolf J, Bodurka DC, Levenback C. Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol Oncol 94(3):746-53, 2004. e-Pub 2004. PMID: 15350368.
- Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C, Gershenson DM. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol 94(2):442-8, 2004. e-Pub 2004. PMID: 15297186.
- Smith JA, Kindo CC, Kurian S, Whitaker LM, Burke C, Wachel B, Sun CC, Weaver CL, Danielson MG, Fitzgerald MA, Munsell M, Zandstra FA, Bodurka DC. Evaluation of patient chemotherapy education in a gynecology oncology center. Support Care Cancer 12(8):577-83, 2004. e-Pub 2004. PMID: 15168104.
- Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?. Obstet Gynecol 104(2):255-60, 2004. e-Pub 2004. PMID: 15291996.
- Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: An exploratory study. Int J Gynecol Cancer 14(4):580-8, 2004. e-Pub 2004. PMID: 15304150.
- Donato ML, Aleman A, Champlin RE, Saliba RM, Wharton JT, Burke TW, Bodurka DC, Bevers MW, Levenback CF, Wolf JK, Bast RC, Freedman RS, Ippoliti C, Brewer M, Gajewski JL, Gershenson DM. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 33(12):1219-24, 2004. e-Pub 2004. PMID: 15122311.
- Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, Silva EG. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 28(4):496-504, 2004. e-Pub 2004. PMID: 15087669.
- Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 22(5):881-9, 2004. e-Pub 2004. PMID: 14990644.
- Silva EG, Deavers MT, Bodurka DC, Malpica A. Uterine epithelioid leiomyosarcomas with clear cells: Reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28(2):244-9, 2004. e-Pub 2004. PMID: 15043315.
- Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, Bodurka DC, Basen-Engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 22(4):671-7, 2004. e-Pub 2004. PMID: 14966090.
- Schimp VL, Worley C, Brunello S, Levenback CC, Wolf JK, Sun CC, Bodurka DC, Ramirez PT. Vacuum-assisted closure in the treatment of gynecologic oncology wound failures. Gynecol Oncol 92(2):586-91, 2004. e-Pub 2004. PMID: 14766251.
- Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback C. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol 90(3):625-8, 2003. e-Pub 2003. PMID: 13678736.
- Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer 98(4):758-64, 2003. e-Pub 2003. PMID: 12910520.
- Brown J, Broaddus R, Koeller M, Burke TW, Gershenson DM, Bodurka DC. Sarcomatoid carcinoma of the cervix. Gynecol Oncol 90(1):23-8, 2003. e-Pub 2003. PMID: 12821337.
- Strasser F, Fisch M, Bodurka DC, Sivesind D, Bruera E. E-motions: Email for Written Emotional Expression. J Clin Oncol 21(9 Suppl):98-101, 2003. e-Pub 2003. PMID: 12743210.
- Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecol Oncol 88(3):363-8, 2003. e-Pub 2003. PMID: 12648588.
- Bodurka DC, Levenback C, Wolf JK, Gano J, Wharton JT, Kavanagh JJ, Gershenson DM. Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer. J Clin Oncol 21(2):291-7, 2003. e-Pub 2003. PMID: 12525521.
- Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Mentorship and productivity among gynecologic oncology fellows. J Cancer Educ 18(1):15-9, 2003. e-Pub 2003. PMID: 12825629.
- Sun CC, Bodurka DC, Donato ML, Rubenstein EB, Borden CL, Basen-Engquist K, Munsell MF, Kavanagh JJ, Gershenson DM. Patient preferences regarding side effects of chemotherapy for ovarian cancer: Do they change over time?. Gynecol Oncol 87(1):118-28, 2002. e-Pub 2002. PMID: 12468352.
- Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20(17):3651-7, 2002. e-Pub 2002. PMID: 12202666.
- Strasser F, Fisch M, Bodurka DC, Sivesind D, Bruera E. E-motions: Email for written emotional expression. J Clin Oncol 20(15):3352-5, 2002. e-Pub 2002. PMID: 12149311.
- Dalrymple JL, Levenback C, Wolf JK, Bodurka DC, Garcia M, Gershenson DM. Trends among gynecologic oncology inpatient deaths: Is end-of-life care improving?. Gynecol Oncol 85(2):356-61, 2002. e-Pub 2002. PMID: 11972400.
- Madoff DC, Toombs BD, Skolkin MD, Bodurka DC, Modesitt SC, Wood CG, Hicks ME. Endovascular management of ureteral-iliac artery fistulae with Wallgraft endoprostheses. Gynecol Oncol 85(1):212-7, 2002. e-Pub 2002. PMID: 11925149.
- Crispens MA, Bodurka DC, Deavers M, Lu K, Silva EG, Gershenson DM. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 99(1):3-10, 2002. e-Pub 2002. PMID: 11777502.
- Verschraegen CF, Kavanagh JJ, Loyer E, Bodurka-Bevers D, Kudelka AP, Hu W, Vincent M, Nelson T, Levenback C. Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer 92(9):2327-33, 2001. e-Pub 2001. PMID: 11745287.
- Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83(2):276-81, 2001. e-Pub 2001. PMID: 11606084.
- Robinson JB, Singh D, Bodurka-Bevers DC, Wharton JT, Gershenson DM, Wolf JK. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecol Oncol 82(3):550-8, 2001. e-Pub 2001. PMID: 11520154.
- Donato ML, Gershenson DM, Wharton JT, Ippoliti CM, Aleman AS, Bodurka-Bevers D, Bevers MW, Burke TW, Levenback CF, Wolf JK, Freedman RS, Bast RC, Jr, Gajewski JL, Champlin RE. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol 82(3):420-6, 2001. e-Pub 2001. PMID: 11520135.
- Verschraegen CF, Benjapibal M, Supakarapongkul W, Levy LB, Ross M, Atkinson EN, Bodurka-Bevers D, Kavanagh JJ, Kudelka AP, Legha SS. Vulvar melanoma at the MD Anderson Cancer Center: 25 years later. Int J Gynecol Cancer 11(5):359-64, 2001. e-Pub 2001. PMID: 11737466.
- Ramondetta L, Burke TW, Levenback C, Bevers M, Bodurka-Bevers D, Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol 82(1):156-61, 2001. e-Pub 2001. PMID: 11426978.
- Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Clin Cancer Res 7(6):1765-72, 2001. e-Pub 2001. PMID: 11410518.
- Munkarah A, Levenback C, Wolf JK, Bodurka-Bevers D, Tortolero-Luna G, Morris RT, Gershenson DM. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol 81(2):237-41, 2001. e-Pub 2001. PMID: 11330956.
- Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S, Gershenson DM. Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol 19(6):1809-17, 2001. e-Pub 2001. PMID: 11251013.
- Gordinier ME, Ramondetta LM, Parker LP, Wolf JK, Follen M, Gershenson DM, Bodurka-Bevers D. Survey of female gynecologic oncologists and fellows: Balancing professional and personal life. Gynecol Oncol 79(2):309-14, 2000. e-Pub 2000. PMID: 11063663.
- Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, Gershenson DM. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 78(3 Pt 1):302-8, 2000. e-Pub 2000. PMID: 10985884.
- Robinson JB, Sun CC, Bodurka-Bevers D, Im DD, Rosenshein NB. Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia. Gynecol Oncol 78(2):235-41, 2000. e-Pub 2000. PMID: 10926809.
- Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JT. Posttherapy surveillance of women with cervical cancer: An outcomes analysis. Gynecol Oncol 78(2):187-93, 2000. e-Pub 2000. PMID: 10926801.
- Donato ML, Gershenson D, Ippoliti C, Wharton JT, Bast RC, Jr, Aleman A, Anderlini P, Gajewski JG, Giralt S, Molldrem J, Ueno N, Lauppe J, Korbling M, Boyer J, Bodurka-Bevers D, Bevers M, Burke T, Freedman R, Levenback C, Wolf J, Champlin RE. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant 25(11):1137-40, 2000. e-Pub 2000. PMID: 10849525.
- Parker LP, Parker JR, Bodurka-Bevers D, Deavers M, Bevers MW, Shen-Gunther J, Gershenson DM. Paget's disease of the vulva: Pathology, pattern of involvement, and prognosis. Gynecol Oncol 77(1):183-9, 2000. e-Pub 2000. PMID: 10739709.
- Donato ML, Champlin RE, Wharton JT, Bodurka-Bevers D, Gershenson D. Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer. Eur J Gynecol Oncol 21:241-4, 2000. e-Pub 2000. PMID: 10949384.
- Wolf JK, Kim TE, Fightmaster D, Bodurka D, Gershenson DM, Mills G, Wharton JT. Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus. Gynecol Oncol 73(1):27-34, 1999. e-Pub 1999. PMID: 10094876.
- Cantor SB, Mitchell MF, Tortolero-Luna G, Bratka CS, Bodurka DC, Richards-Kortum R. Cost-effectiveness analysis of diagnosis and management of cervical squamous intraepithelial lesions. Obstet Gynecol 91(2):270-7, 1998. e-Pub 1998. PMID: 9469288.
- Kurtzman F, Yager J, Landsverk H, Wiesmeier E, Bodurka DC. Eating disorders and associated symptoms among dancers and other student populations at UCLA. Kinesiology and Medicine for Dance 13(1):16-32, 1990. e-Pub 1990. PMID: 2909591.
- Kurtzman FD, Yager J, Landsverk J, Wiesmeier E, Bodurka DC. Eating disorders among selected female student populations at UCLA. J Am Diet Assoc 89(1):45-53, 1989. e-Pub 1989. PMID: 2909591.
- Kurtzman F, Bodurka DC. SNAC: Nutrition education in the university setting. J Nutr Educ 18(6):264B-C, 1986. e-Pub 1986.
Invited Articles
- Prescott LS, Dickens AS, Guerra SL, Tanha JM, Phillips DG, Patel KT, Umberson KM, Lozano MA, Lowe KB, Brown AJ, Taylor JS, Soliman PT, Garcia EA, Levenback CF, Bodurka DC. Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education. Gynecol Oncol 140(suppl 1):114-119, 2015. e-Pub 2015. PMID: 26549108.
- Bodurka DC, Sun CC, Gershenson DM. Review on "Reproductive issues in the gynecologic cancer patient". Oncology 21(5):598-609, 2007. e-Pub 2007. PMID: 11396354.
- Bodurka DC, Sun CC. Sexual function after gynecologic cancer. Obstet Gynecol Clin North Am 33(4):621-30, ix, 2006. e-Pub 2006. PMID: 17116505.
- Sun CC, Frumovitz M, Bodurka DC. Quality of life and gynecologic malignancies. Curr Oncol Rep 7(6):459-65, 2005. e-Pub 2005. PMID: 16221383.
- Bodurka DC. What's new in gynecology and obstetrics. J Am Coll Surg 201(2):265-74, 2005. e-Pub 2005. PMID: 16038826.
- Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Fifth International Conference on Ovarian Cancer: Challenges and opportunities. Gynecol Oncol 97(3):916-23, 2005. e-Pub 2005. PMID: 15907981.
- Bodurka-Bevers D, Gershenson DM. Review on "Mirhashemi/Nieves-Neiral/Averette Article". Oncology 15:593-597, 2001. e-Pub 2001. PMID: 11396354.
Review Articles
- Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC. How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. Cancer Treat Rev 46:1-8, 2016. e-Pub 2016. PMID: 27046422.
- Hoffman MS, Bodurka DC. Surgical education and training program development for gynecologic oncology: American perspective. Gynecol Oncol 114(2 Suppl):S47-51, 2009. e-Pub 2009. PMID: 19573707.
- Sun CC, Ramirez PT, Bodurka DC. Quality of life for patients with epithelial ovarian cancer. Nat Clin Pract Oncol 4(1):18-29, 2007. e-Pub 2007. PMID: 17183353.
- Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: A literature review. Gynecol Oncol 95(1):133-8, 2004. e-Pub 2004. PMID: 15385122.
- Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. Cervical cancer. Cancer 98(9 Suppl):2009-14, 2003. e-Pub 2003. PMID: 14603537.
- Bodurka-Bevers D, Sun CC, Gershenson DM. Pharmacoeconomic considerations in treating ovarian cancer. Pharmacoeconomics 17:133-50, 2000. e-Pub 2000. PMID: 10947337.
Professional Educational Materials
- Bodurka DC. Aligning Residency Training to Changing Societal Needs, The Josiah Macy J. Foundation, 2016.
- . Survivorship in Gynecologic Cancers, Gynecologic Cancer Foundation's State of the State Report, 2009.
- . Helping Cancer Patients with Quality of Life Treatment Decisions, American College of Obstetricians and Gynecologists ACOG Update, 2005.
- . Ovarian Cancer: Quality of Life Issues. National Ovarian Cancer Coalition, 2005.
- . New Diagnostic Tools on the Horizon, 2002.
- . MD Anderson Gynecologic Oncology Handbook, 1996.
Editorials
- Bodurka DC, von Gruenigen V. Women's cancer survivorship: Time to gear up!. Gynecol Oncol 124(3):377-378, 2012. PMID: 22325192.
- Bodurka DC, Schlumbrecht MP. Human papillomavirus vaccine acceptability: Is multimedia education ready for prime time?. Gynecol Oncol 118(2):103-7, 2010. PMID: 20609933.
- Bodurka DC, Sun CC, Frumovitz MM. Quality of life in cervix cancer survivors--what matters the most in the long-term?. Gynecol Oncol 97(2):307-9, 2005. PMID: 15863122.
- Slomovitz BM, Bodurka DC, Lu KH. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?. Obstet Gynecol 105:218-9, 2005. PMID: 15291996.
Abstracts
- Chelariu-Raicu, A, Levenback, CF, Slomovitz, BM, Bodurka DC, Gershenson, DM, Coleman, RL. Phase I/II study of weekly topotecan and gefitinib in patients with platinum-resistant ovarian, peritoneal, or fallopian tube cancer. Journal of Clinical Oncology 38(15 Supplement S), 2020. e-Pub 2020. PMID: 33037105.
- Langabeer, DM, Krause, T, Cazaban, CMG, Swartz, MD, Lopez, DS, Bodurka DC. Are symptoms distinguishable in ovarian cancer? A nested case control study of insurance claims. Journal of Clinical Oncology 38(15 Supplement S), 2020. e-Pub 2020.
- Coleman, RL, Hu, W, Soliman, PT, Nick, AM, Ramirez, PT, Westin, SN, Zu, Z, Schmeler, KM, Bodurka DC, Meyer, LA, Sood, AK. Dasatinib, paclitaxel and carboplatin in women with advanced-stage and recurrent endometrial cancer: A pilot clinical and translational study. Gynecologic Oncology 154(Supplement 1):35-36, 2019. e-Pub 2019. PMID: 33551196.
- Zhukovsky DS, Haider A, SMAA N, Joshi N, Soliman PT, Mathew B, Bodurka DC, Meyer LA, Westin S, Frumovitz M, Archie L, Fenton S, Williams, JL, Boving V. A systematic process to enhance selection of a prepared medical decision maker. Journal of Clinical Oncology 36(34 Supplement S), 2018. e-Pub 2018.
- Taylor JS, Zhang, N, Rajan, SS, Meyer, LA, Ramondetta, LM, Bodurka-Bevers D, Lairson, DR, Giordano, SH. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecologic Oncology 149(Supplement 1):122-122, 2018. e-Pub 2018. PMID: 30876488.
- Michalak, J, Hernandez, M, Laws, A, Jones, L, Bodurka DC, Hajek, R. Potential impact of dietary intervention/counseling on survival in ovarian cancer patients: Results from an observational study. Journal of Clinical Oncology 36(15 Supplement S), 2018. e-Pub 2018.
- Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN. Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device. Obstet Gynecol 131(1):109-116, 2018. e-Pub 2018. PMID: 29215513.
- Zhukovsky DS, Soliman, PT, Mathew, B, Mills, S, Bodurka DC, Meyer, L, Westin, SN, Nowitz, M, Archie, L, Fenton, S, Lang, KE, Williams, JL, Boving, V. Selecting a prepared medical decision maker. Journal of Clinical Oncology 35(31 Supplement S), 2017. e-Pub 2017.
- Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM. Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients. Supportive Care in Cancer 25(6):1985-1991, 2017. e-Pub 2017. PMID: 28175997.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DC. The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients. Int J Gynecol Cancer 27(4):838-846, 2017. e-Pub 2017. PMID: 28399031.
- Shinn EH, Valentine A, Baum G, Carmack C, Kilgore K, Bodurka DC, Basen-Engquist K. Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints. Gynecologic Oncology 145(3):562-568, 2017. e-Pub 2017. PMID: 28400146.
- Meyer, He, Sun, Zhao, Suidan, Lu, Giordano, Bodurka DC. Uptake and outcomes associated with neoadjuvant chemotherapy in the elderly: a population based analysis. Gynecologic Oncology 141:169, 2016. e-Pub 2016.
- Prescott LS, Vergote IB, Coens C, Sun CC, Munsell MF, Casado A, Coleman RL, Bodurka DC. Effect of perioperative blood transfusion on quality of life, progression-free and overall survival in primary treatment of advanced epithelial ovarian cancer: An EORTC ancillary study. Gynecol Oncol 141(suppl 1):198, 2016. e-Pub 2016. PMID: 36356982.
- Westin SN, Sun CCL, Broaddus R, Pal N, Woodall M, Urbauer D, Ramondetta LM, Lu KH, Coleman RL, Bodurka DC. Challenging the paradigm of progesterone-only therapy for early endometrial cancer: Results of a prospective trial of the levonorgestrel intrauterine system. Gynecol Oncol 141(suppl 1):18-19, 2016. e-Pub 2016.
- Taylor JS, Marten CA, Bodurka DC, Burzawa JK, Munsell MF, Potts K, Nick AM, Meyer LA, Levenback CF, Schmeler KM. The DISINFECT initiative: Decreasing the incidence of surgical INFECTions in gynecologic oncology. Gynecol Oncol 141(suppl 1):73, 2016. e-Pub 2016. PMID: 27573526.
- Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment patterns and outcomes for bowel obstruction in elderly ovarian cancer patients: A population-based analysis. Gynecol Oncol 141(suppl 1):131, 2016. e-Pub 2016.
- Gershenson DM, Bodurka DC, Coleman RL, Lu KH, Malpica A, Sun CC. Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum. Journal of Clinical Oncology 35(15 Supplement S):1103-1111, 2016. e-Pub 2016. PMID: 28221866.
- Taylor JS, Zhang N, Meyer L, Ramondetta LM, Bodurka DC, Rajan S, Giordano SH. Changing patterns of hospice and end of life care. Journal of Clinical Oncology 34(15 Supplement S), 2016. e-Pub 2016.
- Taylor JS, Zhang N, Meyer L, Ramondetta LM, Bodurka DC, Rajan S, Giordano SH. When more is less:End-of-life disparities among ovarian cancer patients. J Clin Oncol 34(15 Supplement S), 2016. e-Pub 2016. PMID: 28388292.
- Armbruster SD, Sun CC, Soliman PT, Westin SN, Bodurka DC, Ramondetta LM, Bradford AM, Basen-Engquist K. Prospective assessment of patient perception and quality of life in gynecologic patients after pelvic exenteration. J Clin Oncol 34(15 Supplement S), 2016. e-Pub 2016. PMID: 29622276.
- Taylor JS, Marten C, Potts K, Cloutier L, Cain KE, Fenton S, Tatum T, James D, Hubbs C, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss L, Ware K, Park A, Aloia T, Bodurka DC, Levenback CF, Schmeler KM. What is the real rate of surgical-site infection?. Journal of Clinical Oncology 34(7 Supplement S), 2016. e-Pub 2016. PMID: 27460495.
- Bodurka DC, Ait Aiss M, Phu HP, Day LR, Varkey A, Chen K, Rodrigo M, Razvi S, Gonzalez CE, Brito-Dellan N, Banala S, Rubio D, Vaughn-Adams N, Ruiz DS, Jens T, Levenback CF, Frumovitz MM, Zand B, Escalante CP. Improving Transitions of Care through Implementation of a Standardized Handoff at a Comprehensive Cancer Center. J Clin Oncol 34(7 Supplement S), 2016. e-Pub 2016.
- Banala S, Gonzalez CE, Brito-Dellan N, Rubio D, Ait Aiss M, Rice T, Chen K, Bodurka DC, Escalante CP. Safer transitions of care at a major cancer center: The emergency center to hospitalist experience. Journal of Clinical Oncology 34(7 Supplement S), 2016. e-Pub 2016.
- Gershenson DM, Bodurka DC, Coleman RL, Lu KH, Malpica A, Sun CC. Hormonal maintenance therapy for women with low grade serous carcinoma of the ovary or peritoneum. J Clin Oncol 34, 2016. e-Pub 2016. PMID: 28221866.
- Bruegl AS, Bottsford-Miller JN, Bodurka DC. HPV vaccination practices among American Indian/Alaska Native providers (Poster). Gynecol Oncol 141(suppl 1):132, 2016. e-Pub 2016.
- Brown AJ, Shen MJ, Urbauer D, Taylor JS, Parker P, Carmack C, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. The Advance Care Planning Readiness Scale: A novel measure of gynecologic oncology patients' willingness to discuss and accept end-of-life care. Gynecol Oncol 141(suppl 1):79-80, 2016. e-Pub 2016.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka DC. Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients. Gynecol Oncol 142(suppl 3):525-530, 2016. e-Pub 2016. PMID: 27439968.
- Meyer LA, He W, Sun CC, Zhao H, Suidan RS, Lu KH, Giordano SH, Bodurka DC. Uptake and outcomes associated with neoadjuvant chemotherapy in the elderly: A population-based analysis. Gynecol Oncol 141(suppl 1):169, 2016. e-Pub 2016.
- Kim YJ, Munsell MF, Park CJ, Meyer L, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LM. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Journal of Clinical Oncology 33(29 Supplement S), 2015. e-Pub 2015. PMID: 26432043.
- Prescott, L, Aloia, T, Taylor, J, Sun, C, Levenback, C, Schmeler, K, Bodurka DC. Perioperative blood transfusion in gynecologic surgery: Proceed with caution. Gynecologic Oncology 137:595, 2015. e-Pub 2015. PMID: 25451693.
- Ramondetta LM, Kim YJ, Munsell MF, Park J, Meyer LA, Sun CCL, Brown AJ, Bodurka DC, Bruera E. Symptom burden in women with advanced or recurrent cervical cancer referred to a supportive care center. Gynecol Oncology 137(Supplement 1):197, 2015. e-Pub 2015.
- Meyer LA, He W, Zhao H, Sun CC, Wright A, Bodurka DC, Lu KH, Giordano SH. Patterns of care and survival in a matched case–control study of intraperitoneal chemotherapy in a national population-based cohort of elderly ovarian cancer patients. Gynecologic Oncology 137(Supplement 1):175-176, 2015. e-Pub 2015.
- Taylor JS, Brown AJ, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. How equal is end-of-life care among gynecologic oncology patients?. Gynecologic Oncology 137(Supplement 1):194-195, 2015. e-Pub 2015. PMID: 26706661.
- Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DC. Perioperative blood transfusion in gynecologic oncology surgery: Analysis of the National Surgical Quality Improvement Program Database. Gynecol Oncol 136(suppl 1):65-70, 2015. e-Pub 2015.
Book Chapters
- Bodurka DC, Taylor JS. Training and Future Leaders. In: Ethical Challenges in Oncology. Mosby Elsevier, 2017.
- Shlumbrecht MP, Bodurka DC. Obstetric and Gynecologic Emergencies in Cancer Patients. In: Oncologic Emergencies. Springer, 327-348, 2016.
- Bodurka DC, Frumovitz M. Malignant Diseases of the Vagina. In: Comprehensive Gynecology. 7. Mosby Elsevier, 704-732, 2016.
- Bodurka DC, Frumovitz M. Neoplastic Diseases of the Vulva. In: Comprehensive Gynecology. 7. Mosby Elsevier, 685-703, 2016.
- Previs RA, Bodurka DC. Uterine Cancer Diagnosis and Treatment. In: Diagnosis and Management of Stage II Endometrial Cancer, 293-305, 2015.
- Bodurka DC, Westin SN, Sun CC. Gynecologic Cancer Survivorship Management. In: Advances in Cancer Survivorship Management. Springer, 125-143, 2014.
- Bodurka DC, Frumovitz M. Malignant Diseases of the Vagina. In: Comprehensive Gynecology. Mosby Elsevier, 703-711, 2012.
- Frumovitz M, Bodurka DC. Neoplastic Diseases of the Vulva. In: Comprehensive Gynecology. Mosby Elsevier, 685-702, 2012.
- Frumovitz M, Slomovitz BM, Bodurka DC. Obstetric and Gynecologic Issues. In: Medical Care of Cancer Patients. BC Decker Inc, People's Medical Publishing House, 641-646, 2009.
- Soliman PT, Schmeler KM, Bodurka DC. Sexual Function Issues. In: Medical Care of Cancer Patients. BC Decker Inc, People's Medical Publishing House, 647-652, 2009.
- Schmeler KM, Soliman PT, Bodurka DC. Reproductive Issues. In: Medical Care of Cancer Patients. BC Decker Inc, People's Medical Publishing House, 653-658, 2009.
- Frumovitz M, Bodurka DC. Neoplastic Diseases of the Vulva. In: Comprehensive Gynecology. Mosby Elsevier, 781-800, 2007.
- Bodurka DC, Sun CC. Quality of Life and Sexual Functioning. In: Gynecologic Cancer. Springer-Verlag, 261-278, 2006.
- Basen-Engquist K, Bodurka DC. Medical and Psychosocial Issues in Gynecologic Cancer Survivors. In: Oncology: An Evidence-Based Approach. Springer-Verlag, 1804-1814, 2006.
- Bodurka DC, Sun CC, Basen-Engquist KM. Quality of Life in the Gynecologic Cancer Patient. In: Gynecologic Cancer: Controversies in Management. Elsevier Ltd, 785-794, 2004.
- Bevers MW, Bodurka DC, Wolf JK. Gynecologic Cancers. In: The M. D. Anderson Surgical Oncology Handbook; Third Edition. Lippincott Williams & Wilkins, 445-490, 2003.
- Bodurka DC. Ovarian Cancer. In: The Cambridge Handbook of Advanced Cancer Care. Cambridge University Press, 229-234, 2003.
- Bodurka DC, Wharton JT. Vaginal Cancer. In: Handbook of Gynecologic Oncology, 2nd edition. Martin Dunitz Ltd, 223-229, 2002.
- Bodurka DC, Gershenson DM. Sarcomas of the Female Reproductive Tract. In: Soft Tissue Sarcomas. B.C. Decker Inc, 213-227, 2002.
- Bodurka DC, Burke TW. Obstetric and Gynecologic Emergencies in Cancer Patients. In: Oncologic Emergencies. BC Decker, Inc, 433-440, 2002.
- Bodurka DC, Bevers MW. Preinvasive Disease of the lower female genital tract. In: Handbook of Gynecologic Oncology, 2nd edition. Martin Dunitz Ltd, 203-211, 2002.
- Bodurka DC, Bevers MW, Sukumaran A. Critical Care. In: Handbook of Gynecologic Oncology, 2nd edition. Martin Dunitz Ltd, 91-113, 2002.
- Bodurka DC, Burke TW. Lymphatic Mapping in Patients with Endometrial Cancer. In: Operative Techniques in Gynecologic Surgery, January. W. B. Saunders Company, 38-42, 2001.
- Bodurka DC. Cancer of the Female Lower Genital Tract. In: American Cancer Society Atlas of Clinical Oncology. B. C. Decker Inc, 283-289, 2001.
- Robinson JB, Bodurka DC. Cancer of the Endometrium. In: Advances in Medicine. Vandamere Press, 581-599, 2000.
- Morris M, Bodurka DC. Cervical Cancer. In: Textbook of Gynecology, 2nd Edition. W.B. Saunders, 1261-1287, 2000.
- Bodurka DC, Wharton JT. Vaginal Cancer. In: Handbook of Gynecologic Oncology. Martin Dunitz Ltd, 217-223, 2000.
- Bodurka DC, Follen M, Bevers MW. Preinvasive Disease of the lower female genital tract. In: Handbook of Gynecologic Oncology. Martin Dunitz Ltd, 197-205, 2000.
- Bodurka DC, Bevers MW, Sukumaran A. Critical Care. In: Handbook of Gynecologic Oncology. Martin Dunitz Ltd, 87-109, 2000.
- Mitchell MF, Tortolero-Luna G, Bodurka DC, Morris M. Chapter 26. Cancer and Precursor Lesions of the Uterine Cervix. In: Manual of Clinical Oncology, 7th Edition. International Union Against Cancer (UICC). Wiley-Liss, Inc, 925, 1999.
- Brewer M, Bodurka DC, Edwards C. Gynecologic melanoma. In: Cancer in Women. Blackwell Scientific, 397-403, 1998.
- Bevers MW, Bodurka DC, Wolf JK. Gynecologic Cancers. In: The M. D. Anderson Surgical Oncology Handbook; Second Edition. Lippincott Williams & Wilkins, 377-424, 1998.
- Bodurka DC. Risk Factors and Screening. In: Women's Medicine: A Textbook of Comprehensive Medical Care of the Female. Blackwell Scientific, 3-11, 1996.
Letters to the Editor
- Slomovitz BM, Bodurka DC, Lu KH. In reply: Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?. Obstet Gynecol 105: 218-219, 2005.
Patient Reviews
CV information above last modified July 22, 2026